[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,870,928,974,1095,1175,1220,1304,1393],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":25,"verifyTime":776,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":786,"fullTextUrl":26,"authors":787,"publicationType":747,"publisherRelationship":854,"citationCount":26,"citationInfo":26,"publishDate":868,"publishYear":869,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"4342c456-c360-4277-8e2c-1649fcb7bf79","2023-12-28T12:31:07.555+00:00","2024-12-23T20:05:25.616+00:00",[],"Diagn%C3%B3stico-por-imagen-de-la-endometriosis-p%C3%A9lvica",{"references":780,"title":782,"doi":784},{"VOID":781},"Koninckx, 1991, Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain, Fertil Steril, 55, 759, 10.1016\u002FS0015-0282(16)54244-7\nThomassin, 2004, Symptoms before and after surgical removal of colorectal endometriosis that are assessed by magnetic resonance imaging and rectal endoscopic sonography, Am J Obstet Gynecol, 190, 1264, 10.1016\u002Fj.ajog.2003.12.004\nCornillie, 1990, Deeply infiltrating pelvic endometriosis: histology and clinical significance, Fertil Steril, 53, 978, 10.1016\u002FS0015-0282(16)53570-5\nBazot, 2004, Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis, Ultrasound Obstet Gynecol, 24, 180, 10.1002\u002Fuog.1108\nBazot, 2011, Learning curve of transvaginal ultrasound for the diagnosis of endometriomas assessed by the cumulative summation test (LC-CUSUM), Fertil Steril, 95, 301, 10.1016\u002Fj.fertnstert.2010.08.033\nNisolle, 1997, Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities [see comments], Fertil Steril, 68, 585, 10.1016\u002FS0015-0282(97)00191-X\nBazot, 2004, Deep pelvic endometriosis: MR imaging for diagnosis and prediction of extension of disease, Radiology, 232, 379, 10.1148\u002Fradiol.2322030762\nChapron, 2004, Accuracy of rectal endoscopic ultrasonography and magnetic resonance imaging in the diagnosis of rectal involvement for patients presenting with deeply infiltrating endometriosis, Ultrasound Obstet Gynecol, 24, 175, 10.1002\u002Fuog.1107\nKinkel, 1999, Magnetic resonance imaging characteristics of deep endometriosis, Hum Reprod, 14, 1080, 10.1093\u002Fhumrep\u002F14.4.1080\nBalleyguier, 2002, Comparison of magnetic resonance imaging and transvaginal ultrasonography in diagnosing bladder endometriosis, J Am Assoc Gynecol Laparosc, 9, 15, 10.1016\u002FS1074-3804(05)60099-0\nPiketty, 2009, Preoperative work-up for patients with deeply infiltrating endometriosis: transvaginal ultrasonography must definitely be the first-line imaging examination, Hum Reprod, 24, 602, 10.1093\u002Fhumrep\u002Fden405\nHudelist, 2009, Combination of transvaginal sonography and clinical examination for preoperative diagnosis of pelvic endometriosis, Hum Reprod, 24, 1018, 10.1093\u002Fhumrep\u002Fdep013\nGonçalves MO da C, 2010, Transvaginal ultrasonography with bowel preparation is able to predict the number of lesions and rectosigmoid layers affected in cases of deep endometriosis, defining surgical strategy, Hum Reprod, 25, 665, 10.1093\u002Fhumrep\u002Fdep433\nDessole, 2003, Sonovaginography is a new technique for assessing rectovaginal endometriosis, Fertil Steril, 79, 1023, 10.1016\u002FS0015-0282(02)04952-X\nReid, 2014, Office gel sonovaginography for the diagnosis of posterior deep infiltrating endometriosis: a multicenter prospective observational study, Ultrasound Obstet Gynecol, 44, 710, 10.1002\u002Fuog.13422\nKupfer, 1992, Transvaginal sonographic appearance of endometriomata: spectrum of findings, J Ultrasound Med, 11, 129, 10.7863\u002Fjum.1992.11.4.129\nMais, 1993, The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma, Fertil Steril, 60, 776, 10.1016\u002FS0015-0282(16)56275-X\nPatel, 1999, Endometriomas: diagnostic performance of US [published erratum appears in Radiology 1999 Dec;213(3):930] [see comments], Radiology, 210, 739, 10.1148\u002Fradiology.210.3.r99fe61739\nJain, 1994, Prospective evaluation of adnexal masses with endovaginal gray-scale and duplex and color Doppler US: correlation with pathologic findings [see comments], Radiology, 191, 63, 10.1148\u002Fradiology.191.1.8134599\nGuerriero, 1998, The diagnosis of endometriomas using colour Doppler energy imaging, Hum Reprod, 13, 1691, 10.1093\u002Fhumrep\u002F13.6.1691\nValenzano Menada, 2008, Does transvaginal ultrasonography combined with water-contrast in the rectum aid in the diagnosis of rectovaginal endometriosis infiltrating the bowel?, Hum Reprod, 23, 1069, 10.1093\u002Fhumrep\u002Fden057\nPhilip, 2015, Three-dimensional (3D) rectosonography: description of a new 3D transvaginal ultrasonography technique with intrarectal contrast to assess colorectal endometriosis, Ultrasound Obstet Gynecol, 45, 233, 10.1002\u002Fuog.13446\nGuerriero, 2014, Three-dimensional ultrasonography in the diagnosis of deep endometriosis, Hum Reprod, 29, 1189, 10.1093\u002Fhumrep\u002Fdeu054\nBazot, 2011, Value of thin-section oblique axial T2-weighted magnetic resonance images to assess uterosacral ligament endometriosis, Hum Reprod, 26, 346, 10.1093\u002Fhumrep\u002Fdeq336\nBazot, 2005, Sonography and MR imaging for the assessment of deep pelvic endometriosis, J Minim Invasive Gynecol, 12, 178, 10.1016\u002Fj.jmig.2005.01.014\nTakeuchi, 2005, A novel technique using magnetic resonance imaging jelly for evaluation of rectovaginal endometriosis, Fertil Steril, 83, 442, 10.1016\u002Fj.fertnstert.2004.08.021\nTogashi, 1991, Endometrial cysts: diagnosis with MR imaging, Radiology, 180, 73, 10.1148\u002Fradiology.180.1.2052726\nGhezzi, 2005, “Kissing ovaries”: a sonographic sign of moderate to severe endometriosis, Fertil Steril, 83, 143, 10.1016\u002Fj.fertnstert.2004.05.094\nChapron, 2003, Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease, Hum Reprod, 18, 760, 10.1093\u002Fhumrep\u002Fdeg152\nDonnez, 2000, Bladder endometriosis must be considered as bladder adenomyosis, Fertil Steril, 74, 1175, 10.1016\u002FS0015-0282(00)01584-3\nAbrao, 2007, Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis, Hum Reprod, 22, 3092, 10.1093\u002Fhumrep\u002Fdem187\nTanaka, 2000, Ovarian carcinoma in patients with endometriosis: MR imaging findings, AJR Am J Roentgenol, 175, 1423, 10.2214\u002Fajr.175.5.1751423\nRousset, 2014, Bowel endometriosis: preoperative diagnostic accuracy of 3.0-T MR enterography–initial results, Radiology, 273, 117, 10.1148\u002Fradiol.14132803\nChapron, 2003, Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification, Hum Reprod, 18, 157, 10.1093\u002Fhumrep\u002Fdeg009\nFein, 1966, Vesical endometriosis: a case report and review of the literature, J Urol, 95, 45, 10.1016\u002FS0022-5347(17)63405-0\nFedele, 1998, Bladder endometriosis: deep infiltrating endometriosis or adenomyosis?, Fertil Steril, 69, 972, 10.1016\u002FS0015-0282(98)00048-X\nBazot, 2012, The value of MRI in assessing parametrial involvement in endometriosis, Hum Reprod, 27, 2352, 10.1093\u002Fhumrep\u002Fdes211\nHarada, 1992, [A case of ureteral endometriosis; the usefulness of MRI for preoperative diagnosis], Hinyokika Kiyo, 38, 207\nBazot, 2007, Accuracy of transvaginal sonography and rectal endoscopic sonography in the diagnosis of deep infiltrating endometriosis, Ultrasound Obstet Gynecol, 30, 994, 10.1002\u002Fuog.4070\nBazot, 2009, Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis, Fertil Steril, 92, 1825, 10.1016\u002Fj.fertnstert.2008.09.005\nRoseau, 2014, Recto-sigmoid endoscopic-ultrasonography in the staging of deep infiltrating endometriosis, World J Gastrointest Endosc, 6, 525, 10.4253\u002Fwjge.v6.i11.525",{"ES":783},"Diagnóstico por imagen de la endometriosis pélvica",{"VOID":785},"10.1016\u002Fs1283-081x(17)85962-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X17859622",[788,803,818,830,842],{"id":789,"sortIndex":114,"researcher":26,"roles":790,"affiliations":791,"properties":800},"42d27a1f-4443-4a85-a019-34317dae4df1",[696],[792],{"id":26,"sortIndex":36,"affiliation":793,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":796,"slug":26,"properties":797,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e4e27a99-55e7-4114-9175-b65871a972f7","2023-12-28T12:31:07.587+00:00",[],{"title":798},{"VI":799},"Gynécologie-obstétrique et médecine de la reproduction, Hôpital Tenon, Groupe hospitalier Paris-Est, AP–HP, Université Pierre-et-Marie-Curie, 4, rue de la Chine, 75020 Paris, France",{"title":801},{"VI":802},"M.K. Ballester",{"id":804,"sortIndex":59,"researcher":26,"roles":805,"affiliations":806,"properties":815},"47c53883-ddf2-4292-b13d-d8f554dd35cc",[696],[807],{"id":26,"sortIndex":36,"affiliation":808,"properties":26},{"id":809,"createTime":810,"updateTime":810,"relativeEntities":811,"slug":26,"properties":812,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a1dbd9b0-f92c-41bd-92dd-ed0429abc926","2023-12-28T12:31:07.577+00:00",[],{"title":813},{"VI":814},"Service de radiologie, Hôpital Tenon, Groupe hospitalier Paris-Est, AP–HP, Université Pierre-et-Marie-Curie, 4, rue de la Chine, 75020 Paris, France",{"title":816},{"VI":817},"M. Bazot",{"id":819,"sortIndex":111,"researcher":26,"roles":820,"affiliations":821,"properties":827},"95e1e738-c242-4dfd-b2b4-e1d8c17dc308",[696],[822],{"id":26,"sortIndex":36,"affiliation":823,"properties":26},{"id":794,"createTime":795,"updateTime":795,"relativeEntities":824,"slug":26,"properties":825,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":826},{"VI":799},{"title":828},{"VI":829},"E. Daraï",{"id":831,"sortIndex":115,"researcher":26,"roles":832,"affiliations":833,"properties":839},"06d835e0-94f5-48f6-93e2-8dc1d8ce559b",[696],[834],{"id":26,"sortIndex":36,"affiliation":835,"properties":26},{"id":809,"createTime":810,"updateTime":810,"relativeEntities":836,"slug":26,"properties":837,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":838},{"VI":814},{"title":840},{"VI":841},"B. Fedida",{"id":843,"sortIndex":36,"researcher":26,"roles":844,"affiliations":845,"properties":851},"5b626dab-6d12-4ec9-ad55-da96c793a2c7",[696],[846],{"id":26,"sortIndex":36,"affiliation":847,"properties":26},{"id":809,"createTime":810,"updateTime":810,"relativeEntities":848,"slug":26,"properties":849,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":850},{"VI":814},{"title":852},{"VI":853},"I. Thomassin-Naggara",{"url":786,"publisher":855,"properties":863},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":856,"slug":662,"properties":857,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":860,"manageAffiliations":861,"indexDatabases":862,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":858,"title":859},{"VOID":665},{"EN":667},[],[],[],{"volume":864,"pages":866},{"VOID":865},"53",{"VOID":867},"1-10","2017-09-01",2017,{"id":871,"createTime":872,"updateTime":873,"relativeEntities":874,"slug":875,"properties":876,"entityType":688,"verifyStatus":25,"verifyTime":873,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":883,"fullTextUrl":26,"authors":884,"publicationType":747,"publisherRelationship":912,"citationCount":26,"citationInfo":26,"publishDate":926,"publishYear":927,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"bf8617d8-c88d-4fe1-8e7d-1fff27d79f4e","2024-01-24T12:49:31.502+00:00","2024-12-24T07:14:34.913+00:00",[],"Tumores-de-la-vagina-y-lesiones-similares",{"references":877,"title":879,"doi":881},{"VOID":878},"Ali, 1996, Radiation alone for carcinoma of the vagina: variation in response related to the location of the primary tumor, Cancer, 77, 1934, 10.1002\u002F(SICI)1097-0142(19960501)77:9\u003C1934::AID-CNCR25>3.0.CO;2-#\n1988, Vagina, 169\nAnderson, 1985, Endodermal sinus tumors of the vagina. The role of primary chemotherapy, Cancer, 56, 1025, 10.1002\u002F1097-0142(19850901)56:5\u003C1025::AID-CNCR2820560509>3.0.CO;2-X\nAntonioli, 1980, Natural history of DES-associated genital tract lesions: cervical ectopy and cervicovaginal hood, Am j Obstet Cynecon, 137, 847, 10.1016\u002F0002-9378(80)90898-4\nAudet-Lapointe, 1990, Vaginal intraepithelial neoplasia, Gynecol Oncol, 36, 232, 10.1016\u002F0090-8258(90)90180-S\nBall, 1982, Management of primary vaginal carcinoma, Gynecol Oncol, 14, 154, 10.1016\u002F0090-8258(82)90085-3\nBenedet, 1984, Carcinoma in situ of the vagina, Am J Obstet Gynecol, 148, 695, 10.1016\u002F0002-9378(84)90776-2\nBenson, 1993, Neovaginal reconstruction with a rectus abdominis myocutaneous flap, Obstet Gynecol, 81, 871\nBornstein, 1987, Human Papillomavirus associated with vaginal intraepithelial neoplasia in women exposed to diethylstilbestrol in útero, Obstet Gynecol, 70, 75\nBrinton, 1990, Case-control study of in situ and invasive carcinoma of the vagina, Gynecol Oncol, 38, 49, 10.1016\u002F0090-8258(90)90010-I\nChyle, 1996, Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors, Int J Radiat Oncol Biol Phys, 35, 891, 10.1016\u002F0360-3016(95)02394-1\nCopeland, 1985, Sarcoma botryoides of the female genital tract, Obstet Gynecol, 66, 262\nCurtin, 1995, Soft-tissue sarcoma of the vagina and vulva: a clinico-pathologic study, Obstet Gynecol, 86, 269, 10.1016\u002F0029-7844(95)00160-S\nDaly, 1980, Treatment of vaginal dysplasía and carcinoma in situ with topical 5-fluro-uracil, Obstet Gynecol, 55, 350, 10.1097\u002F00006250-198003000-00016\nDancuart, 1988, Primary squamous cell carcinoma of the vagina treated by radiotherapy: a failure analysis. The MD Anderson Hospital experience 1955–1982, Int I Radiat Oncol Biol Phys, 14, 745, 10.1016\u002F0360-3016(88)90097-1\nDargent, 1992, Reconstruction du vagin aprés les opérations radicales et supraradicales, Can Oncol, 1, 35\nDavis, 1991, Invasive vaginal carcinoma: analysis of early-stage disease, Gynecol Oncol, 42, 131, 10.1016\u002F0090-8258(91)90332-Y\nDavos, 1976, Sarcoma of the vagina, Obstet Gynecol, 47, 342\nDi Saïa, 1996, Tumors of the vagina\nDixit, 1993, Squamous cell carcinoma of the vagina, Gynecol Oncol, 48, 80, 10.1006\u002Fgyno.1993.1013\nDzikonski, 1979, Gartner's duct carcinoma of vagina in pregnancy, Zentralbl Gynaecol, 101, 1595\nEddy, 1991, Underwood PD. Primary invasive vaginal carcinoma, Am J Obstet Gynecol, 165, 292, 10.1016\u002F0002-9378(91)90081-2\nElliott, 1967, Pseudo-sarcoma botryoides of cervix and vagina in pregnancy, J Obstet Gynaecol Br Commonw, 74, 728, 10.1111\u002Fj.1471-0528.1967.tb03787.x\nGerbaulet, 1993, L'adénocarcinome á cellules claires du col et du vagin de la jeune filie : DES syndrome. Possibilité de traitement conservateur, Bull Cancer\u002FRadiother, 80, 291\nGerbaulet, 1989, Conservative treatment for lower gynecological tract malignancies in children and adolescents: the institut Gustave Roussy's experience, Int J Radiat Oncol Biol Phys, 17, 655, 10.1016\u002F0360-3016(89)90119-3\nHarwood, 1982, Radiotherapy for mucosal melanomas, Int J Radiat Oncol Biol Phys, 8, 1121, 10.1016\u002F0360-3016(82)90058-X\nHays, 1988, Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents, Cancer, 61, 1893, 10.1002\u002F1097-0142(19880501)61:9\u003C1893::AID-CNCR2820610929>3.0.CO;2-9\nHerbst, 1990, Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol, Semin Surg Oncol, 6, 343, 10.1002\u002Fssu.2980060609\nHerbst, 1977, Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix, Am J Obstet Gynecol, 128, 43, 10.1016\u002F0002-9378(77)90293-9\nHerbst, 1979, An analysísof 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival, Gynecol Oncol, 7, 111, 10.1016\u002F0090-8258(79)90087-8\nHerbst, 1971, Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women, N Engl J Med, 284, 878, 10.1056\u002FNEJM197104222841604\nHilgers, 1975, Pelvicexenteration forvaginal embryonal rhabdomyosarcoma: a review, Obstet Gynecol, 45, 175\nHoffman, 1992, Upper vaginectomy for in situ and occult, superficially invasive carcinoma of the vagina, Am J Obstet Gynecol, 166, 30, 10.1016\u002F0002-9378(92)91823-S\nIkenberg, 1990, Human Papillomavirus DNA ín invasive carcinoma of the vagina, Obstet Gynecol, 76, 432\nImrie, 1986, Intraepithelial neoplasia arising in an artificial vagina, Br J Obstet Cynaecol, 93, 886, 10.1111\u002Fj.1471-0528.1986.tb08000.x\nJobson, 1983, Treatment of vaginal intraepithelial neoplasia with the carbon dioxide, Obstet Gynecol, 62, 90\nJones, 1987, Clear-cell adenocarcinoma of the lower genital tract: Memorial Hospital 1974–1984, Obstet Gynecol, 70, 573\njoseph, 1992, Small cell neuroendocrine carcinoma of the vagina, Cancer, 70, 784, 10.1002\u002F1097-0142(19920815)70:4\u003C784::AID-CNCR2820700412>3.0.CO;2-0\nKaufman, 1989, Cystic tumors\nKirkbride, 1995, Carcinoma of the vagina: experience at the Princess Margaret Hospital (1974–1989) [review], Gynecol Oncol, 56, 435, 10.1006\u002Fgyno.1995.1077\nKottmeier, 1963, The classification and clinical staging of carcinoma of the uterus and vagina, J Int Fed Gynecol Obstet, 1, 83\nKucera, 1991, Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival, Gynecol Oncol, 40, 12, 10.1016\u002F0090-8258(91)90076-H\nKurman, 1992, Tumors of the vagin\nLee, 1994, Radiotherapy alone for carcinoma of the vagina: the importance of overall treatment time, Int J Radiat Oncol Biol Phys, 29, 983, 10.1016\u002F0360-3016(94)90392-1\nLefranc, 1988, Cancer invasif sur épithélium néoformé aprés clivage recto-vaginal pour absence congénitale de vagin. Étude anatomo-clinique, virologique et thérapeutique, Gynécologie, 39, 477\nLenehan, 1986, Vaginal intraepithelial neoplasia: biologic aspects and management, Obstet Gynecol, 68, 333, 10.1097\u002F00006250-198609000-00008\nLeung, 1993, Radical radiation therapy for carcinoma of the vagina-impact of treatment modalities on outcome: Peter MacCallum Cancer Institute experience 1970–1990, Int J Radiat Oncol Biol Phys, 25, 413, 10.1016\u002F0360-3016(93)90061-Y\nLeverger, 1983, Tumeurs du sac vitellin de localisation vaginale chez l'enfant, Arch Fr Pédiatr, 40, 85\nMalkasian, 1963, Primary leiomyosarcoma of the vagina: a study of 8 cases, Am J Obstet Gynecol, 86, 730, 10.1016\u002FS0002-9378(16)35186-9\nMerino, 1991, Vaginal Cancer: the role of infectious and environmental factors, Am J Obstet Gynecol, 165, 1255, 10.1016\u002FS0002-9378(12)90738-3\nMunkarah, 1994, Mucinous adenocarcinoma arising in a neo-vagina, Gynecol Oncol, 52, 272, 10.1006\u002Fgyno.1994.1045\nNanavati, 1993, High-dose rate brachytherapy in primary stage I and II vaginal Cancer, Gynecol Oncol, 51, 67, 10.1006\u002Fgyno.1993.1248\nNoller, 1983, Maturation of vaginal and cervical epithelium in women exposed in utero to diethylstilbestrol (DESAD project), Am J Obstet Gynecol, 146, 279, 10.1016\u002F0002-9378(83)90749-4\nPastogi, 1984, Primary leiomysarcoma of the vagina: a study of five cases, Gynecol Oncol, 18, 77, 10.1016\u002F0090-8258(84)90009-X\nPerez, 1982, Long-term follow-up in radiation therapy of carcinoma of the vagina, Cancer, 49, 1308, 10.1002\u002F1097-0142(19820315)49:6\u003C1308::AID-CNCR2820490639>3.0.CO;2-G\nPerez, 1998, Vagina, 1891\nPerez, 1999, Factors affecting long-term outcome of irradiation in carcinoma of the vagina, Int J Radiat Oncol Biol Phys, 44, 37, 10.1016\u002FS0360-3016(98)00530-6\nPerren, 1992, Lymphomas of the cervix and upper vagina: a report of fíve cases and review of the literature, Gynecol Oncol, 44, 87, 10.1016\u002F0090-8258(92)90018-E\nPfister, 1996, The role of human Papillomavirus in anogenital Cancer, Obstet Gynecol Clin Nonth Am, 23, 579\nPiver, 1979, Postirradiation squamous cell carcinoma in situ of the vagina: treatment by topical 20 % 5-flurouracil cream, Am J Obstet Gynecol, 135, 377, 10.1016\u002F0002-9378(79)90709-9\nPiver, 1988, Long-term follow-up and complications of infants with vulvovaginal embryonal rhabdomyosarcoma treated with surgery, radiation therapy, and chemotherapy, Obstet Gynecol, 71, 435\nPlenti, 1971, Lymphatic system of the female genitalia\nProppe, 1984, Postoperative spindle cell nodules of genitourinary tract resembling sarcomas: a report of eight cases, Am J Surg Pathol, 8, 101, 10.1097\u002F00000478-198402000-00003\nRagnarsson-Olding, 1993, Malignant melanoma of the vagina, Cancer, 71, 1893, 10.1002\u002F1097-0142(19930301)71:5\u003C1893::AID-CNCR2820710528>3.0.CO;2-7\nRagni, 1974, Primary malignant melanoma of the vagina and vulva, Obstet Gynecol, 43, 658\nRaney, 1990, Primary chemotherapy with or without radiation therapy and\u002For surgery for children with localized sarcoma of the bladder prostate vagina uterus and cervix: a comparison of the results in intergroup rhabdomyosarcoma studies I and II, Cancer, 66, 2072, 10.1002\u002F1097-0142(19901115)66:10\u003C2072::AID-CNCR2820661006>3.0.CO;2-9\nReddy, 1991, Results ofradiotherapeutic management of primary carcinoma of the vagina, Int J Radiat Oncol Biol Phys, 21, 1041, 10.1016\u002F0360-3016(91)90747-R\nRichart, 1986, The incidence of cervical and vaginal dysplasia after exposure to DES, JAMA, 255, 36, 10.1001\u002Fjama.1986.03370010038013\nRobboy, 1986, Vaginal adenosis prior to the DES era, Hum Pathol, 17, 488, 10.1016\u002FS0046-8177(86)80039-9\nRobboy, 1984, Increased incidence of cervical et vaginal dysplasia in 3 980 diethylstilbestrol-exposed young women: experience of the National Collaboration diethylstilbestrol adenosis project, JAMA, 252, 2979, 10.1001\u002Fjama.1984.03350210027024\nRobboy, 1981, Role of hormones including DES in the pathogenesis of cervical and vaginal intra-epithelial neoplasia, Gynecol Oncol, 12, S98, 10.1016\u002F0090-8258(81)90065-2\nRobboy, 1981, Dysplasia and cytologic findings in 4.589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project, Am J Obstet Gynecol, 140, 579, 10.1016\u002F0002-9378(81)90236-2\nRobboy, 1984, Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring, Cancer, 54, 869, 10.1002\u002F1097-0142(19840901)54:5\u003C869::AID-CNCR2820540519>3.0.CO;2-I\nSandberg, 1980, Diethylstilbestrol-exposed monozygot twins discordant for cervicovaginal clear cell carcinoma, Am J Obstet Gynecol, 137, 220, 10.1016\u002F0002-9378(80)90778-4\nScheider, 1987, Multifocal squamous neoplasia of the female genital tract: significance of human Papillomavirus infection of the vagina after hysterectomy, Obstet Gynecol, 70, 292\nSedlacek, 1990, Vaginal and vulvar adenosis. An unsuspected side effect of CO2 laser vaporization, J Reprod Med, 35, 995\nSenekjian, 1987, Local therapy in stage I clear cell adenocarcinoma of the vagina, Cancer, 60, 1319, 10.1002\u002F1097-0142(19870915)60:6\u003C1319::AID-CNCR2820600626>3.0.CO;2-H\nSenekjian, 1989, Pelvic exenteration in clear cell adenocarcinoma of the vaginal and cervix, Gynecol Oncol, 34, 413, 10.1016\u002F0090-8258(89)90183-2\nSenekjian, 1988, An evaluation of stage II vaginal clear cell adenocarcinoma according to substages, Gynecol Oncol, 31, 56, 10.1016\u002F0090-8258(88)90269-7\nSillman, 1985, A review of lower genital intraepithelial neoplasia and the use of topical 5-fluo-rouracil, Obstet Gynecol Surv, 40, 190, 10.1097\u002F00006254-198504000-00002\nStock, 1995, A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities, Gynecol Oncol, 56, 45, 10.1006\u002Fgyno.1995.1008\nStock, 1992, The importance of brachytherapy technique in the management of primary carcinoma of the vagina, Int J Radiat Oncol Biol Phys, 24, 747, 10.1016\u002F0360-3016(92)90724-V\nStuart, 1988, Laser vaporization of vaginal intraepithelial neoplasia, Am J Obstet Gynecol, 158, 240, 10.1016\u002F0002-9378(88)90130-5\nSugase, 1997, Distinct manifestations of human Papillomavirus in the vagina, Int J Cancer, 72, 412, 10.1002\u002F(SICI)1097-0215(19970729)72:3\u003C412::AID-IJC7>3.0.CO;2-S\nTavassoli, 1979, Smouth muscle tumors of the vagina, Obstet Gynecol, 53, 689\nThigpen, 1986, Phase II trial of cisplatin in advanced or recurrent Cancer of the vagina: a gynecologic oncology group study, Gynecol Oncol, 23, 101, 10.1016\u002F0090-8258(86)90121-6\nTownsend, 1982, Treatment of vaginal carcinoma in situ with the carbon dioxide láser, Am J Obstet Gynecol, 143, 565, 10.1016\u002F0002-9378(82)90548-8\nTurner-Warwick, 1990, The construction and reconstruction of the vaginal with the colocecum, Surg Gynecol Obstet, 170, 132\nVan Nostrand, 1994, Primary vaginal melanoma: improved survival with radical pelvic surgery, Gynecol Oncol, 55, 234, 10.1006\u002Fgyno.1994.1283\nWelch, 1985, Pathology of colposcopic findings in 2 635 diethylstilbestrol exposed young women, Gynecol Oncol, 21, 277, 10.1016\u002F0090-8258(85)90264-1\nWright, 1992, Intraepithelial neoplasia of the lower female genital tract: etiology investigation and management, Semin Surg Oncol, 8, 180, 10.1002\u002Fssu.2980080403\nYoung, 1984, Endodermal sinus tumor of the vagina: a report of nine cases and review of the literature, Gynecol Oncol, 18, 380, 10.1016\u002F0090-8258(84)90050-7\nZaino, 1994, Diseases of the vagina\nZurhausen, 1995, Are human Papillomavirus infections not necessary or sufficient causal factors for invasive Cancer of the cervix, Int J Cancer, 63, 315, 10.1002\u002Fijc.2910630228",{"ES":880},"Tumores de la vagina y lesiones similares",{"VOID":882},"10.1016\u002Fs1283-081x(01)71891-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X01718917",[885,900],{"id":886,"sortIndex":115,"researcher":26,"roles":887,"affiliations":888,"properties":897},"fb94b185-5214-40e6-8111-62894030b407",[696],[889],{"id":26,"sortIndex":36,"affiliation":890,"properties":26},{"id":891,"createTime":892,"updateTime":892,"relativeEntities":893,"slug":26,"properties":894,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a3e5192d-ff1d-41aa-9060-8d8c7b3d9b40","2024-01-04T16:47:54.677+00:00",[],{"title":895},{"VI":896},"Service d'oncologie-radiothérapie, centre des tumeurs, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France",{"title":898},{"VI":899},"E. Deniaud-Alexandre",{"id":901,"sortIndex":36,"researcher":26,"roles":902,"affiliations":903,"properties":909},"3f864368-9a9b-4a8d-b580-cde769d3f09a",[696],[904],{"id":26,"sortIndex":36,"affiliation":905,"properties":26},{"id":891,"createTime":892,"updateTime":892,"relativeEntities":906,"slug":26,"properties":907,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":908},{"VI":896},{"title":910},{"VI":911},"E. Touboul",{"url":883,"publisher":913,"properties":921},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":914,"slug":662,"properties":915,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":918,"manageAffiliations":919,"indexDatabases":920,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":916,"title":917},{"VOID":665},{"EN":667},[],[],[],{"volume":922,"pages":924},{"VOID":923},"37",{"VOID":925},"1-14","2001-01-01",2001,{"id":929,"createTime":930,"updateTime":931,"relativeEntities":932,"slug":933,"properties":934,"entityType":688,"verifyStatus":25,"verifyTime":931,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":941,"fullTextUrl":26,"authors":942,"publicationType":747,"publisherRelationship":958,"citationCount":26,"citationInfo":26,"publishDate":972,"publishYear":973,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"fa4a3443-64fe-470a-90f1-edbb010d6bf5","2023-12-31T20:05:16.605+00:00","2024-12-28T05:25:41.023+00:00",[],"Histolog%C3%ADa-y-fisiolog%C3%ADa-del-endometrio-normal",{"references":935,"title":937,"doi":939},{"VOID":936},"O'Rahilly, 1989, Prenatal human development\nPelliniemi, 1980, The fetal gonad and sexual differentiation\nPasqualini, 1983, NGuyen BL, Gelly C, et al. Progesterone receptor during fetal development\nMacLaughlin, 1983, Specific estradiol binding in embryonic Mullerian ducts: a potential modulator of regression in the male and female chick, Endocrinology, 113, 141, 10.1210\u002Fendo-113-1-141\nFerenczy, 1980, Regeneration of the human endometrium\nBergeron, 1988, Immuno-cytochemical study of progesterone receptors in the human endometrium during the menstrual cycle, Lab. Invest., 59, 862\nGarcia, 1988, Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating, J. Clin. Endocrinol. Metab., 67, 80, 10.1210\u002Fjcem-67-1-80\nLessey, 1988, Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle, J. Clin. Endocrinol. Metab., 67, 334, 10.1210\u002Fjcem-67-2-334\nPress, 1984, Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle, Lab. Invest., 51, 495\nGurpide, 1977, Estrogen metabolism in normal and neoplastic endometrium, Am. J. Obstet. Gynecol., 129, 809, 10.1016\u002F0002-9378(77)90401-X\nEnmark, 1999, Oestrogen receptors: an overview, J. Intern. Med., 246, 133, 10.1046\u002Fj.1365-2796.1999.00545.x\nLecce, 2001, Presence of ERβ in the human endometrium through the cycle: expression in glandular, stromal and vascular cells, J. Clin. Endocrinol. Metab., 86, 1379, 10.1210\u002Fjc.86.3.1379\nFujimoto, 1998, Expression of progesterone receptor form A and B mRNAs in uterine leiomyoma, Tumour Biol., 19, 126, 10.1159\u002F000029983\nWang, 1998, Progesterone receptor subtype B is differentially regulated in human endometrial stroma, Mol. Hum. Reprod., 4, 407, 10.1093\u002Fmolehr\u002F4.4.407\nVegeto, 1993, Human progesterone receptor A form is a cell-and promoter specific repressor of human progesterone receptor B function, Mol. Endocrinol., 7, 1244, 10.1210\u002Fme.7.10.1244\nKleinman, 1983, Human endometrium in cell culture: a new method for culturing human endometrium as separate epithelial and stromal components, Arch. Gynecol., 234, 103, 10.1007\u002FBF00207682\nTaketani, 1991, Evidence for direct regulation of epidermal growth factor receptors by steroid hormones in human endometrial cells, Hum. Reprod., 6, 1365, 10.1093\u002Foxfordjournals.humrep.a137269\nMurphy, 1987, Estrogen induces insulin-like growth factor-I expression in the rat uterus, Mol. Endocrinol., 1, 445, 10.1210\u002Fmend-1-7-445\nHorowitz, 1993, Immunohistochemical localization of transforming growth factor-alpha in human endometrium, decidua, and trophoblast, J. Clin. Endocrinol. Metab., 76, 786, 10.1210\u002Fjc.76.3.786\nBerchuck, 1989, Epidermal growth factor receptor expression in normal and malignant endometrium, Am. J. Obstet. Gynecol., 161, 1247, 10.1016\u002F0002-9378(89)90676-5\nHofmann, 1991, Immunohistochemical localization of epidermal growth factor in human endometrium, decidua, and placenta, J. Clin. Endocrinol. Metab., 73, 882, 10.1210\u002Fjcem-73-4-882\nEjskjaer, 2005, Expression of the epidermal growth factor system in human endometrium during the menstrual cycle, Mol. Hum. Reprod., 11, 543, 10.1093\u002Fmolehr\u002Fgah207\nMukku, 1985, Regulation of epidermal growth factor receptor by estrogen, J. Biol. Chem., 260, 9820, 10.1016\u002FS0021-9258(17)39309-2\nBargmann, 1986, The neu oncogene encodes an epidermal growth factor receptor-related protein, Nature, 319, 226, 10.1038\u002F319226a0\nBerchuck, 1991, Overexpression of HER-2\u002Fneu in endometrial cancer is associated with advanced stage disease, Am. J. Obstet. Gynecol., 164, 15, 10.1016\u002F0002-9378(91)90615-X\nBigsby, 1992, Immunohistochemical study of HER-2\u002Fneu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium, Obstet. Gynecol., 79, 95\nHetzel, 1992, HER-2\u002Fneu expression: a major prognostic factor in endometrial cancer, Gynecol. Oncol., 47, 179, 10.1016\u002F0090-8258(92)90103-P\nOdom, 1989, Immunocytochemical study of ras and myc proto-oncogene polypeptide expression in the human menstrual cycle, Am. J. Obstet. Gynecol., 161, 1663, 10.1016\u002F0002-9378(89)90946-0\nMurphy, 1987, Estrogen induction of N-myc and c myc proto-oncogene expression in the rat uterus, Endocrinology, 120, 1882, 10.1210\u002Fendo-120-5-1882\nFerenczy, 1983, Endometrial microstructure: structure-function relationships throughout the menstrual cycle, Semin. Reprod. Endocrinol., 1, 205, 10.1055\u002Fs-2008-1067956\nNoyes, 1950, Dating the endometrial biopsy, Fertil. Steril., 1, 3, 10.1016\u002FS0015-0282(16)30062-0\nFerenczy, 1991, Histology of the human endometrium: from birth to senescence. In: The primate endometrium, Ann. N. Y. Acad. Sci., 622, 6, 10.1111\u002Fj.1749-6632.1991.tb37847.x\nDabbs, 1986, Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns, Am. J. Surg. Pathol., 10, 568, 10.1097\u002F00000478-198608000-00007\nRavn, 1992, Mucin-type carbohydrates (type 3 chain antigens) in normal cycling human endometrium, Int. J. Gynecol. Pathol., 11, 38, 10.1097\u002F00004347-199201000-00007\nRebello, 1975, A study of the secretory immune system of the female genital tract, Br. J. Obstet. Gynaecol., 82, 812, 10.1111\u002Fj.1471-0528.1975.tb00578.x\nSatyaswaroop, 1982, Endocrinology, 111, 743, 10.1210\u002Fendo-111-3-743\nGibson, 1991, Error in histologic dating of secretory endometrium: variance component analysis, Fertil. Steril., 56, 242, 10.1016\u002FS0015-0282(16)54479-3\nLi, 1989, How precise is histologic dating of endometrium using the standard dating criteria?, Fertil. Steril., 51, 759, 10.1016\u002FS0015-0282(16)60662-3\nMore, 1974, The morphogenesis and fate of the nucleolar channel system in the human endometrial glandular cells, J. Ultrastruct. Res., 47, 74, 10.1016\u002FS0022-5320(74)90027-6\nWilkinson, 1990, Nucleolar organiser regions in normal, hyperplastic and neoplastic endometria, Int. J. Gynecol. Pathol., 9, 55, 10.1097\u002F00004347-199001000-00005\nVon Rango, 1998, The receptive endometrium is characterized by apoptosis in the glands, Hum. Reprod., 13, 3177, 10.1093\u002Fhumrep\u002F13.11.3177\nNikas, 1997, Uterine pinopodes in peri-implantation human endometrium. Clinical relevance, Ann. N. Y. Acad. Sci., 816, 129, 10.1111\u002Fj.1749-6632.1997.tb52136.x\nJoshi, 1983, Progestin-regulated proteins of the human endometrium, Semin. Reprod. Endocrinol., 1, 221, 10.1055\u002Fs-2008-1067957\nStewart, 1992, Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor, Nature, 359, 76, 10.1038\u002F359076a0\nWaites, 1988, Immunohistological localization of the human endometrial secretory protein pregnancy-associated endometrial alpha1-globulin, an insulin-like growth factor-binding protein, during the menstrual cycle, J. Clin. Endocrinol. Metab., 67, 1100, 10.1210\u002Fjcem-67-5-1100\nGruidl, 1997, The progressive rise in the expression of alpha crystallin B chain in human endometrium is initiated during the implantation window: modulation of gene expression by steroid hormones, Mol. Hum. Reprod., 3, 333, 10.1093\u002Fmolehr\u002F3.4.333\nAplin, 1996, MUC1 as a cell surface and secretory component of endometrial epithelium: reduced levels in recurrent miscarriage, Am. J. Reprod. Immunol., 35, 261, 10.1111\u002Fj.1600-0897.1996.tb00042.x\nLessey, 1995, Integrins as markers of uterine receptivity in women with primary unexplained infertility, Fertil. Steril., 63, 535, 10.1016\u002FS0015-0282(16)57422-6\nAplin, 1988, An immunohistochemical study of human endometrial extracellular matrix during the menstrual cycle and the first trimester of pregnancy, Cell Tissue Res., 253, 231, 10.1007\u002FBF00221758\nCreus, 1998, Integrin expression in normal and out-of –phase endometria, Hum. Reprod., 13, 3460, 10.1093\u002Fhumrep\u002F13.12.3460\nNeulen, 1988, Effects of estradiol-17beta and progesterone on the synthesis of prostaglandin F2alpha, prostaglandin E2 and prostaglandin I2 by fibroblasts from human endometrium in vitro, Prostaglandins, 36, 17, 10.1016\u002F0090-6980(88)90099-8\nSmith, 1984, Effect of 17beta-estradiol and progesterone on the levels of prostaglandin F2alpha and E in human endometrium, Prostaglandins, 27, 591, 10.1016\u002F0090-6980(84)90094-7\nPerrot-Applanat, 1988, Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans, Endocrinology, 123, 1511, 10.1210\u002Fendo-123-3-1511\nKearns, 1983, Life history of decidual cells: a review, Am. J. Reprod. Immunol., 3, 78, 10.1111\u002Fj.1600-0897.1983.tb00219.x\nWewer, 1985, Immunochemical and ultrastructural assessment of the nature of the pericellular basement membrane of human decidual cells, Lab. Invest., 53, 624\nDe Ziegler, 1992, Effect of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins, J. Clin. Endocrinol. Metab., 74, 322, 10.1210\u002Fjc.74.2.322\nWaites, 1988, Immunohistological localization of human endometrial secretory protein, pregnancy-associated endometrial alpha2-globulin (alpha2-PEG) during the menstrual cycle, J. Reprod. Fertil., 82, 665, 10.1530\u002Fjrf.0.0820665\nHuang, 1987, Regulation of prolactin production by progestin, estrogen and relaxin in human endometrial stromal cells, Endocrinology, 121, 2011, 10.1210\u002Fendo-121-6-2011\nLawn, 1971, The ultrastructure of human decidual and predecidual cells, J. Reprod. Fertil., 26, 85, 10.1530\u002Fjrf.0.0260085\nIwahashi, 1996, Decreased type IV collagen expression by human decidual tissues in spontaneous abortion, J. Clin. Endocrinol. Metab., 81, 2925, 10.1210\u002Fjc.81.8.2925\nBulmer, 1985, Immuno-histological characterization of the decidual leucocytic infiltrate related to endometrial gland epithelium in early human pregnancy, Immunology, 55, 35\nPadykula, 1989, Regeneration in the primate uterus. The role of stem cells\nChiquet-Ehrismann, 1989, Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interactions of MCF7 cells and fibroblasts, Cancer Res., 49, 4322\nVollmer, 1990, Tenascin expression in the human endometrium and in endometrial adenocarcinomas, Lab. Invest., 62, 725\nMcClellan, 1986, Immunocytochemical localization of estrogen receptors in the macaque endometrium during the luteal-follicular transition, Endocrinology, 119, 2467, 10.1210\u002Fendo-119-6-2467",{"ES":938},"Histología y fisiología del endometrio normal",{"VOID":940},"10.1016\u002Fs1283-081x(06)47901-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X06479017",[943],{"id":944,"sortIndex":36,"researcher":26,"roles":945,"affiliations":946,"properties":955},"d1bd9941-22b2-46f2-ad52-36096094ba7b",[696],[947],{"id":26,"sortIndex":36,"affiliation":948,"properties":26},{"id":949,"createTime":950,"updateTime":950,"relativeEntities":951,"slug":26,"properties":952,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d862d3fe-7447-4aa6-a457-d76d1bd7854e","2023-12-31T06:18:26.702+00:00",[],{"title":953},{"VI":954},"Laboratoire Pasteur-Cerba, 95066 Cergy Pontoise cedex 9, France",{"title":956},{"VI":957},"C. Bergeron",{"url":941,"publisher":959,"properties":967},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":960,"slug":662,"properties":961,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":964,"manageAffiliations":965,"indexDatabases":966,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":962,"title":963},{"VOID":665},{"EN":667},[],[],[],{"volume":968,"pages":970},{"VOID":969},"42",{"VOID":971},"1-8","2006-01-01",2006,{"id":975,"createTime":976,"updateTime":977,"relativeEntities":978,"slug":979,"properties":980,"entityType":688,"verifyStatus":25,"verifyTime":977,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":987,"fullTextUrl":26,"authors":988,"publicationType":747,"publisherRelationship":1079,"citationCount":26,"citationInfo":26,"publishDate":1093,"publishYear":1094,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"9dac1a2f-9e9e-44ee-91b7-0c105ee6a2b4","2024-01-05T23:33:02.102+00:00","2024-12-29T13:09:21.099+00:00",[],"Infecci%C3%B3n-bacteriana-maternofetal",{"references":981,"title":983,"doi":985},{"VOID":982},"Schrag, 2002\nAgence nationale d'accréditation et d'évaluation en santé. Recommandations pour la pratique cliniquePrévention anténatale du risque infectieux bactérien néonatal précoce. rapport 136p.www.anaes.fr.\nBonacorsi, 2001, Facteurs de virulence associés à E. coli responsable de méningite néonatale, Arch. Pediatr., 8, 726s, 10.1016\u002FS0929-693X(01)80188-3\nQuentin, 1997, Flore bactérienne génitale chez la femme enceinte, J. Gynecol. Obstet. Biol. Reprod. (Paris), 26, 9\nQuentin, 2003, Infections materno-fœtales : les prélèvements bactériologiques, 301\nBorderon, 1994, Value of examination of the gastric aspirate for the diagnosis of neonatal infection, Biol. Neonate, 65, 353, 10.1159\u002F000244065\nQuentin, 2000, Les infections du nouveau-né: aspects fondamentaux, facteurs de virulence et physiopathologie, 82\nMcDonald, 1991, Vaginal infection and preterm labour, Br. J. Obstet. Gynaecol., 98, 427, 10.1111\u002Fj.1471-0528.1991.tb10335.x\nHillier, 1992, Characteristics of three vaginal flora patterns assessed by gram stain among pregnant womenVaginal infections and prematurity study group, Am. J. Obstet. Gynecol., 166, 938, 10.1016\u002F0002-9378(92)91368-K\nSchuchat, 1994, Multistate case-control study of maternal risk factors for neonatal Group B streptococcal disease, Pediatr. Infect. Dis. J., 13, 623, 10.1097\u002F00006454-199407000-00008\n1996, Prevention of perinatal group B streptococcal disease: a public health perspective, MMWR Morb Mortal Wkly Rep, 45, 1\nAlouf, 1998, Streptococcus agalactiae, 593\nQuentin, 1997, Prélèvements vaginaux et endocervicaux : quand et comment les réaliser?, J. Gynecol. Obstet. Biol. Reprod. (Paris), 26, 29\nSteiger D. Marqueurs de souches de Streptococcus agalactiae à haut risque infectieux: validation et prévalence chez la femme enceinte. 1999 [thèse]. Tours, université François Rabelais 102p.\nBenitz, 1999, Risk factors for early-onset group b streptococcal sepsis: estimation of odds ratios by critical literature review, Pediatrics, 103, e77, 10.1542\u002Fpeds.103.6.e77\nBlond, 1997, Quels sont les risques liés aux portages vaginaux et aux infections génitales basses pour la mère, le fœtus et le nouveau-né?, J. Gynecol. Obstet. Biol. Reprod. (Paris), 26, 13\nBlond, 2001, Infection bactérienne néonatale par contamination maternofœtale : pour un changement de paradigme? I. Dépistage de l'infection à Streptococcus agalactiae : modalités et bilan des effets, J. Gynecol. Obstet. Biol. Reprod. (Paris), 30, 521\nMeyn, 2002, Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women, Am. J. Epidemiol., 155, 949, 10.1093\u002Faje\u002F155.10.949\nTerry, 1999, Risk factors for maternal colonization with group B beta-hemolytic streptococci, J. Am. Osteopath. Assoc., 99, 571, 10.7556\u002Fjaoa.1999.99.11.571\nDavies, 2001, Antibodies to capsular polysaccharides of group B streptococcus in pregnant canadian women: relationship to colonization status and infection in the neonate, J. Infect. Dis., 184, 285, 10.1086\u002F322029\nKrohn, 1999, Maternal peripartum complications associated with vaginal group B streptococci colonization, J. Infect. Dis., 179, 1410, 10.1086\u002F314756\nFeikin, 2001, Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women, Am. J. Obstet. Gynecol., 184, 427, 10.1067\u002Fmob.2001.109936\n1997, Revised guidelines for prevention of early-onset group B Streptococcal (GBS) infection, Pediatrics, 99, 489, 10.1542\u002Fpeds.99.3.489\nMoylett, 2000, A 5-year old recurrent group B streptococcal disease: lessons from twin infants, Clin. Infect. Dis., 30, 282, 10.1086\u002F313655\nOlver, 2000, Neonatal group B streptococcal disease associated with infected breast milk, Arch. Dis. Child., 83, F48, 10.1136\u002Ffn.83.1.F48\nDavies, 2001, Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation, Pediatr. Infect. Dis. J., 20, 879, 10.1097\u002F00006454-200109000-00011\nKrohn, 1997, Vaginal colonization by Escherichia coli as a risk factor for very low birth weight delivery and other perinatal complications, J. Infect. Dis., 175, 606, 10.1093\u002Finfdis\u002F175.3.606\nBlond, 1991, Infection bactérienne du nouveau-né par contamination materno-fœtale : étude épidémiologique rétrospective dans une maternité, J. Gynecol. Obstet. Biol. Reprod. (Paris), 20, 443\nSchuchat, 2000, Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study, Pediatrics, 105, 21, 10.1542\u002Fpeds.105.1.21\nFriedman, 2000, Neonatal Escherichia coli infections: concerns regarding resistance to current therapy, Acta Paediatr., 89, 686, 10.1111\u002Fj.1651-2227.2000.tb00365.x\nHuang, 2000, Bacterial penetration across the blood-brain barrier during the development of neonatal meningitis, Microbes Infect., 2, 1237, 10.1016\u002FS1286-4579(00)01277-6\nQuentin, 1987, Infections materno-fœtales à Haemophilus Influenzae, Presse Med., 16, 1181\nQuentin, 1993, Genetic characterization of a cryptic genospecies of Haemophilus causing urogenital and neonatal infections, J. Clin. Microbiol., 31, 1111, 10.1128\u002FJCM.31.5.1111-1116.1993\nBlond, 2001, Infection bactérienne néonatale par contamination materno-fœtale : pour un changement de paradigme? II. Incertitudes et propositions, J. Gynecol. Obstet. Biol. Reprod. (Paris), 30, 533\nGarcia, 1997, Maternal-fetal vertical transmission of Haemophilus influenzae and Haemophilus parainfluenzae, Enferm Infect Microbiol Clin, 15, 65\nHitchins, 2001, Food-borne Listeria monocytogenes risk assessment, Food Addit. Contam., 18, 1108, 10.1080\u002F02652030110050104\nAouaj, 2002, Listeria monocytogenes meningitis: serotype distribution and patient characteristics in The Netherlands, 1976-95, Epidemiol. Infect., 128, 405, 10.1017\u002FS0950268802006969\nMylonakis, 2002, Listeriosis during pregnancy: a case series and review of 222 cases, Medicine, 81, 260, 10.1097\u002F00005792-200207000-00002\nGoulet, 2001, La surveillance de la listeriose humaine en France en 1999, Bull Epidémiol Hebd, 34\nBerche, 1999, Physiopathologie et diagnostic des infections materno-infantiles à Listeria monocytogenes, MT pédiatrie, 2, 33\nRecommandations Listériose. http:\u002F\u002Fwww.invs.sante.fr\u002Fpublications\u002Flisteriose\u002Freclist.html.\nNouveau dispositif de notification anonymisée des maladies infectieuses à déclaration obligatoire. http:\u002F\u002Fwww.invs.sante.fr\u002Fsurveillance\u002Fmdo\u002Findex.htm Bull Epidémiol Hebd 2003; 12-13: 69-76 Circulaire DGS\u002FSD5C\u002FSD6A n 2003\u002F60.\nGoulet V, Rocourt J, Staïner F, Thomas JC. Impact des mesures de contrôle mises en œuvre depuis 10 ans sur l'incidence de la listériose. http\u002F\u002Fwww.invs.sante.fr\u002Fpublications\u002Fjournees\u002F2\u002Fgoulet\u002Findex.html.\nSingh, 2000, Colonization of the female urogenital tract with Streptococcus pneumoniae and implications for neonatal disease, Pediatr. Infect. Dis. J., 19, 260, 10.1097\u002F00006454-200003000-00021\nGomez, 1999, Neonatal Streptococcus pneumoniae infection: case reports and review of the literature, Pediatr. Infect. Dis. J., 18, 1014, 10.1097\u002F00006454-199911000-00016\nde Alba Romero, 2001, Pneumococci: a new microorganism in the newborn?, An. Esp. Pediatr., 54, 390, 10.1016\u002FS1695-4033(01)77547-9\nPrimhak, 1993, Pneumococcal infection in the newborn, Arch. Dis. Child., 69, 317, 10.1136\u002Fadc.69.3_Spec_No.317\nHughes, 2001, Neonatal pneumococcal sepsis in association with fatal maternal pneumococcal sepsis, Aust. N. Z. J. Obstet. Gynaecol., 41, 457, 10.1111\u002Fj.1479-828X.2001.tb01331.x\nKayemba, 2000, Infection néonatale à Streptococcus pneumoniae, Arch. Pediatr., 7, 1012, 10.1016\u002FS0929-693X(00)90026-5\nVerboon-Maciolek, 2000, Severe neonatal group A streptococcal disease, Eur. J. Pediatr., 159, 450, 10.1007\u002Fs004310051305\nBarnham, 2001, Bacteraemic Streptococcus pyogenes infection in the peri-partum period: now a rare disease and prior carriage by the patient may be important, J. Infect., 43, 173, 10.1053\u002Fjinf.2001.0887\nPanaro, 1993, Intrapartum transmission of group A streptococcus, Clin. Infect. Dis., 17, 79, 10.1093\u002Fclinids\u002F17.1.79\nAndre, 2000, Maternal-fetal staphylococcal infections: a series report, Am. J. Perinatol., 17, 423, 10.1055\u002Fs-2000-13455\nWatier, 2001, Développement de l'immunité: physiopathologie des infections néonatales, 350\nBlond, 2000, Les défenses anti-infectieuses. L'infection bactérienne néonatale, 183\nSpellerberg, 2000, Pathogenesis of neonatal Streptococcus agalactiae infections, Microbes Infect., 2, 1733, 10.1016\u002FS1286-4579(00)01328-9\nLanghendries, 2001, Prévention de l'allergie : et si tout (ou presque) se jouait à la naissance?, Arch. Pediatr., 8, 1037, 10.1016\u002FS0929-693X(01)00579-6\nLanghendries, 1998, Acquisition de la flore intestinale néonatale : rôle sur la morbidité et perspectives thérapeutiques, Arch. Pediatr., 5, 644, 10.1016\u002FS0929-693X(98)80172-3\nSudo, 1997, The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction, J. Immunol., 159, 1739\nBerner, 2001, Different cytokine expression in cord blood mononuclear cells after stimulation with neonatal sepsis or colonizing strains of Streptococcus agalactiae, Pediatr. Res., 49, 691, 10.1203\u002F00006450-200105000-00014\nRolland, 1999, Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis, J. Clin. Microbiol., 37, 1892, 10.1128\u002FJCM.37.6.1892-1898.1999\nChatellier, 1997, Characterization of Streptococcus agalactiae strains by randomly amplified polymorphic DNA analysis, J. Clin. Microbiol., 35, 2573, 10.1128\u002FJCM.35.10.2573-2579.1997\nBerner, 2002, Polymorphisms in the cell wall-spanning domain of the C protein beta-antigen in clinical Streptococcus agalactiae isolates are caused by genetic instability of repeating DNA sequences, Pediatr. Res., 51, 106, 10.1203\u002F00006450-200201000-00019\nSundell, 2000, Isolation and identification of the group B streptococcal toxin CM101 from infants with sepsis, J. Pediatr., 137, 338, 10.1067\u002Fmpd.2000.107839\nBingen, 1998, Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains, J. Infect. Dis., 177, 642, 10.1086\u002F514217\nJohnson, 2001, Escherichia coli O18: K1: H7 isolates from patients with acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profiles, J. Infect. Dis., 183, 425, 10.1086\u002F318086\nJohnson, 2002, Phylogenetic distribution of virulence-associated genes among Escherichia coli isolates associated with neonatal bacterial meningitis in the Netherlands, J. Infect. Dis., 185, 774, 10.1086\u002F339343\nBingen, 1996, Genotyping may provide rapid identification of Escherichia coli K1 organisms that cause neonatal meningitis, Clin. Infect. Dis., 22, 152, 10.1093\u002Fclinids\u002F22.1.152\nBingen, 1997, Virulence patterns of Escherichia coli K1 strains associated with neonatal meningitis, J. Clin. Microbiol., 35, 2981, 10.1128\u002FJCM.35.11.2981-2982.1997\nCook, 2001, Virulence factors of Escherichia coli isolated from female reproductive tract infections and neonatal sepsis, Infect. Dis. Obstet. Gynecol., 9, 203, 10.1155\u002FS1064744901000333\nKhan, 2002, Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 invasion of the central nervous system, J. Biol. Chem., 277, 15607, 10.1074\u002Fjbc.M112224200\nHordnes, 1996, Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women, Infect. Immun., 64, 1643, 10.1128\u002FIAI.64.5.1643-1652.1996\nCampbell, 2000, Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery, Obstet. Gynecol., 96, 498, 10.1016\u002FS0029-7844(00)00977-7\nAbitzsch, 2001, Detection of cervical immunoglobulin A in normal pregnancy, J. Perinat. Med., 29, 36, 10.1515\u002FJPM.2001.005\nZaleznik, 2000, Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups, Clin. Infect. Dis., 30, 276, 10.1086\u002F313665\nBaker, 1976, Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection, N. Engl. J. Med., 294, 753, 10.1056\u002FNEJM197604012941404\nLachenauer, 2002, Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum, J. Infect. Dis., 185, 368, 10.1086\u002F338773\nClegg, 1984, Pilus-mediated adherence of Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types, Infect. Immun., 45, 299, 10.1128\u002FIAI.45.1.299-301.1984\nCox, 1990, Prevention of Escherichia coli K1 bacteremia in newborn mice by using topical vaginal carbohydrates, J. Infect. Dis., 162, 9878, 10.1093\u002Finfdis\u002F162.4.978\nWullenweber, 1993, Influence of some bacterial and host factors on colonization and invasiveness of Escherichia coli K1 in neonatal rats, Infect. Immun., 61, 2138, 10.1128\u002FIAI.61.5.2138-2144.1993\nGlode, 1977, Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E coli K1, Infect. Immun., 16, 75, 10.1128\u002FIAI.16.1.75-80.1977\nBonacorsi, 2003, Epidémiologie bactérienne des infections materno-fœtales, 335\nHyde, 2002, Active Bacterial Core surveillance (ABCs) of the Emerging Infections Program Network.Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta, Pediatrics, 110, 690, 10.1542\u002Fpeds.110.4.690\nBaltimore, 2001, Early-onset neonatal sepsis in the era of group B streptococcal prevention, Pediatrics, 108, 1094, 10.1542\u002Fpeds.108.5.1094\nIsaacs, 1999, Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia, Pediatr. Infect. Dis. J., 18, 524, 10.1097\u002F00006454-199906000-00009\nPersson, 2002, Septicaemia and meningitis in neonates and during early infancy in the Goteborg area of Sweden, Acta Paediatr., 91, 1087, 10.1080\u002F080352502760311593\nStoll, 2002, Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants, N. Engl. J. Med., 347, 240, 10.1056\u002FNEJMoa012657\nBrozanski, 2000, Effect of a screening-based prevention policy on prevalence of early-onset group B streptococcal sepsis, Obstet. Gynecol., 95, 496, 10.1016\u002FS0029-7844(99)00595-5\nTruong, 2000, Reduction of early-onset group B streptoccal sepsis with universal screening and intrapartum antimicrobial therapy for preterm and colonized term parturients, Obstet. Gynecol., 95, S8, 10.1016\u002FS0029-7844(00)00585-8\nde la Rosa Fraile, 2001, Prevention of group B streptococcal neonatal disease: a plea for a European consensus, Clin. Microbiol. Infect., 7, 25, 10.1046\u002Fj.1469-0691.2001.00196.x\nKalliola, 1999, Neonatal group B streptococcal disease in Finland: a ten-year nationwide study, Pediatr. Infect. Dis. J., 18, 806, 10.1097\u002F00006454-199909000-00012\nHafner, 1998, Group B streptococci during pregnancy: a comparison of two screening and treatment protocols, Am. J. Obstet. Gynecol., 179, 677, 10.1016\u002FS0002-9378(98)70063-8\nBeardsall, 2000, Neonatal group B streptococcal infection in South Bedfordshire, 1993-1998, Arch. Dis. Child., 82, F205, 10.1136\u002Ffn.82.3.F205\nMoses, 1998, Early onset group B streptococcal neonatal infection in Oxford 1985-96, Arch. Dis. Child., 79, F148, 10.1136\u002Ffn.79.2.F148\nOddie, 2002, Risk factors for early onset neonatal group B streptococcal sepsis: case-control study, BMJ, 325, 308, 10.1136\u002Fbmj.325.7359.308\nAavitsland, 1996, Systemic group B streptococcal disease in neonates and young infants in Norway 1985-94, Acta Paediatr., 85, 104, 10.1111\u002Fj.1651-2227.1996.tb13900.x\nBedford Russell, 2001, Confirmed group B streptococcus infection: the tip of the iceberg, Arch. Dis. Child., 84, F140, 10.1136\u002Ffn.84.2.F140\nBenitz, 1999, Preventing eearly-onset Group B streptococcal sepsis: strategy development using decision analysis, Pediatrics, 103, e76, 10.1542\u002Fpeds.103.6.e76\nSchuchat, 1998, Epidemiology of group B streptococcal disease in the United States: shifting paradigms, Clin. Microbiol. Rev., 11, 497, 10.1128\u002FCMR.11.3.497\nBromberger, 2000, The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants, Pediatrics, 106, 244, 10.1542\u002Fpeds.106.2.244\nEmbleton, 1999, Mortality from early onset group B streptococcal infection in the United Kingdom, Arch. Dis. Child., 80, F139, 10.1136\u002Ffn.80.2.F139\nEmbleton, 2001, Fetal and neonatal death from maternally acquired infection, Paediatr. Perinat. Epidemiol., 15, 54, 10.1046\u002Fj.1365-3016.2001.00314.x\nBennet, 1989, The outcome of neonatal septicemia during fifteen years, Acta Paediatr. Scand., 78, 40, 10.1111\u002Fj.1651-2227.1989.tb10884.x\nGrimwood, 2002, Early-onset neonatal group B streptococcal infections in New Zealand 1998-1999, Paediatr Child Health, 38, 272, 10.1046\u002Fj.1440-1754.2002.00783.x\nKatz, 1999, Group B streptococcus: to culture or not to culture?, J. Perinatol., 19, 337, 10.1038\u002Fsj.jp.7200191\nHolt, 2001, Neonatal meningitis in England and Wales: 10 years on, Arch. Dis. Child., 84, F85, 10.1136\u002Ffn.84.2.F85\nCulhane, 2002, Exposure to chronic stress and ethnic differences in rates of bacterial vaginosis among pregnant women, Am. J. Obstet. Gynecol., 187, 1272, 10.1067\u002Fmob.2002.127311\nGuise, 2000, Screening for bacterial vaginosis in pregnancy: a meta-analysis, Obstet. Gynecol., 95, S7, 10.1016\u002FS0029-7844(00)00583-4\nGuise, 2001, Screening for bacterial vaginosis in pregnancy, Am. J. Prev. Med., 20, 62, 10.1016\u002FS0749-3797(01)00256-2\nCarey, 2000, Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis, N. Engl. J. Med., 342, 534, 10.1056\u002FNEJM200002243420802\nBerghella, 2002, Sexual intercourse association with asymptomatic bacterial vaginosis and Trichomonas vaginalis treatment in relationship to preterm birth, Am. J. Obstet. Gynecol., 187, 1277, 10.1067\u002Fmob.2002.127134\nGotoff, 1997, Prevention of early-onset neonatal group B streptococcal disease, Pediatrics, 99, 866, 10.1542\u002Fpeds.99.6.866\nRosenstein, 1997, Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis, Obstet. Gynecol., 90, 901, 10.1016\u002FS0029-7844(97)00486-9\nLevine, 1998, Intrapartum management relating to the risk of perinatal transmission of group B streptococcus, Infect. Dis. Obstet. Gynecol., 6, 25, 10.1155\u002FS1064744998000064\nHager, 2000, Prevention of perinatal group B streptococcal infection: current controversies, Obstet. Gynecol., 96, 141, 10.1016\u002FS0029-7844(00)00848-6\nKatz, 1994, Group B streptococci: results of a protocol of antepartum screening and intrapartum treatment, Am. J. Obstet. Gynecol., 170, 521, 10.1016\u002FS0002-9378(94)70221-7\nAnthony, 1978, Epidemiology of group B streptococcus: longitudinal observations during pregnancy, J. Infect. Dis., 137, 524, 10.1093\u002Finfdis\u002F137.5.524\nBoyer, 1983, Selective intrapartum chemoprophylaxis of neonatal goup B streptococcal early-onset disease. II. predictive value of prenatal cultures, J. Infect. Dis., 148, 802, 10.1093\u002Finfdis\u002F148.5.802\nAllardice, 1982, Perinatal goup B streptococcal colonization and infection, Am. J. Obstet. Gynecol., 142, 617, 10.1016\u002FS0002-9378(16)32429-2\nHoogkamp-Korstanje, 1982, Maternal carriage and neonatal acquisition of group B streptococci, J. Infect. Dis., 145, 800, 10.1093\u002Finfdis\u002F145.6.800\nHalle, 1987, Untersuchungen zur Häufigkeit von B Streptokokken Erkrankungen und Besiedelung - eine klinish epidemiologische Studie, Zentralbl. Gynakol., 109, 830\nRegan, 1996, Colonization with group B streptococci in pregnancy and adverse outcome, Am J Obstet Gynecol, 174, 1354, 10.1016\u002FS0002-9378(96)70684-1\nStoll, 1998, Maternal carriage of group B streptococci in developing countries, Pediatr. Infect. Dis. J., 17, 499, 10.1097\u002F00006454-199806000-00013\nWerawatakul, 2001, Prevalence and risk factors of Streptococcus agalactiae (group B) colonization in mothers and neonatal contamination at Srinagarind Hospital, J. Med. Assoc. Thai., 84, 1422\nGrimwood, 2002, Late antenatal carriage of group B Streptococcus by New Zealand women, Aust. N. Z. J. Obstet. Gynaecol., 42, 182, 10.1111\u002Fj.0004-8666.2002.00182.x\nSchuchat, 1994, Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development, Epidemiol. Rev., 16, 374, 10.1093\u002Foxfordjournals.epirev.a036159\nLim, 1986, Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis, J. Clin. Microbiol., 23, 489, 10.1128\u002FJCM.23.3.489-492.1986\nYancey, 1996, Risk factors for neonatal sepsis, Obstet. Gynecol., 87, 188, 10.1016\u002F0029-7844(95)00402-5\nStrickland, 1990, Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization, Am. J. Obstet. Gynecol., 163, 4, 10.1016\u002FS0002-9378(11)90654-1\nJones, 1984, Group B streptococcal colonization patterns in mothers and in their infants, J. Clin. Microbiol., 20, 438, 10.1128\u002FJCM.20.3.438-440.1984\nBurman, 1992, Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labourThe Swedish Chlorhexidine Study Group, Lancet, 340, 65, 10.1016\u002F0140-6736(92)90393-H\nLejeune, 1999, Conduite à tenir face à une colonisation materno-infantile à streptocoques du groupe B, MT Pédiatrie, 1, 47\nVigneswaran, 1995, Prevention of early onset group B streptococcal sepsis in the newborn, J. Paediatr. Child Health, 31, 493, 10.1111\u002Fj.1440-1754.1995.tb00869.x\nKlebanoff, 1995, Outcome of the vaginal infections and prematurity study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci, Am. J. Obstet. Gynecol., 172, 1540, 10.1016\u002F0002-9378(95)90493-X\nHall, 1976, Antibiotic treatment of parturient women colonized with group B streptococci, Am. J. Obstet. Gynecol., 124, 630, 10.1016\u002F0002-9378(76)90065-X\nGardner, 1979, Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study, Am. J. Obstet. Gynecol., 135, 1062, 10.1016\u002F0002-9378(79)90737-3\nLewin, 1981, Natural history of group B streptococcus colonization and its therapy during pregnancy, Am. J. Obstet. Gynecol., 139, 512, 10.1016\u002F0002-9378(81)90509-3\n1996, Acog committee opinion. Committee on obstetric pratice american college of obstetricians and gynecologists. Prevention of early-onset group B streptococcal disease in newborns, Int. J. Gynaecol. Obstet., 54, 197, 10.1016\u002FS0020-7292(96)90083-1\nBoyer, 1983, Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III, J. Infect. Dis., 148, 810, 10.1093\u002Finfdis\u002F148.5.810\nBoyer, 1986, Prevention of early-onset group B streptococcal disease with selective intra-partum chemoprophylaxis, N. Engl. J. Med., 314, 1665, 10.1056\u002FNEJM198606263142603\n1992, Guidelines for prevention of group B streptococcal infection by chemoprophylaxis, Pediatrics, 90, 775, 10.1542\u002Fpeds.90.5.775\nAllen, 1993, Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of a meta-analysis, CMAJ, 149, 1659\nSchrag, 2000, Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis, N. Engl. J. Med., 342, 15, 10.1056\u002FNEJM200001063420103\nGervasio, 2001, Early-onset neonatal group B streptococcal sepsis: intrapartum antibiotic prophylaxis in the clinical setting, J. Perinatol., 21, 9, 10.1038\u002Fsj.jp.7200476\nGilson, 2000, Prevention of group B streptococcus early-onset neonatal sepsis: comparison of the center for disease control and prevention screening-based protocol to a risk-based protocol in infants at greater than 37 weeks'gestation, J. Perinatol., 20, 491, 10.1038\u002Fsj.jp.7200463\nVolumenie, 2001, Neonatal group B streptococcal infection. Results of 33 months of universal maternal screening and antibioprophylaxis, Eur. J. Obstet. Gynecol. Reprod. Biol., 94, 79, 10.1016\u002FS0301-2115(00)00340-7\nPoulain, 1997, Selective intrapartum anti-bioprophylaxy of group B streptococci infection of neonates: a prospective study in 2454 subsequent deliveries, Eur J Obstet Gynecol Reprod Med, 72, 137, 10.1016\u002FS0301-2115(96)02677-2\nRouse, 1994, Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis, Obstet. Gynecol., 83, 483, 10.1097\u002F00006250-199404000-00001\nSchrag, 2002, Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates, N. Engl. J. Med., 347, 233, 10.1056\u002FNEJMoa020205\n2000, Centers for disease control and prevention. Early-onset Group B streptococcal disease: United States, 1998-1999, MMWR Morb. Mortal. Wkly. Rep., 49, 793\nReisner, 2000, Performance of a group B streptococcal prophylaxis protocol combining high-risk treatment and low-risk screening, Am. J. Obstet. Gynecol., 182, 1335, 10.1067\u002Fmob.2000.106246\nLin, 2001, The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease, Am J Obstet Gynecol, 184, 1204, 10.1067\u002Fmob.2001.113875\nMain, 2000, Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols, Am. J. Obstet. Gynecol., 182, 1344, 10.1067\u002Fmob.2000.106245\nLocksmith, 1999, Maternal and neonatal infection rates with three different protocols for prevention of group B streptococcal disease, Am. J. Obstet. Gynecol., 180, 416, 10.1016\u002FS0002-9378(99)70225-5\nSmaill, 2000, Intrapartum antibiotics for group B streptococcal colonisation, Cochrane Database Syst. Rev., 2\nHalliday, 2000, Universal maternal screening for neonatal group B streptococcal disease, Lancet, 356, 1407, 10.1016\u002FS0140-6736(00)02846-4\nSchuchat, 2001, Group B streptococcal disease: from trials and tribulations to triumph and trepidation, Clin. Infect. Dis., 33, 751, 10.1086\u002F322697\nTowers, 1999, Incidence of intrapartum maternal risk factors for identifying neonates at risk for early-onset group B streptococcal sepsis: a prospective study, Am. J. Obstet. Gynecol., 181, 1197, 10.1016\u002FS0002-9378(99)70108-0\nWendel, 2002, Prevention of neonatal group B streptococcal disease: a combined intrapartum and neonatal protocol, Am. J. Obstet. Gynecol., 186, 618, 10.1067\u002Fmob.2002.122970\nLin, 2001, Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study, J Infect Dis, 184, 1022, 10.1086\u002F323350\n2002, Centers for disease control. Revision of guidelines for the prevention of perinatal group B streptococcal disease, JAMA, 287, 1106, 10.1001\u002Fjama.287.9.1106\n2002, Canadian task force on preventive health care. Prevention of group B streptococcal infection in newborns: Recommendation statement from the Canadian Task Force on Preventive Health Care, CMAJ, 166, 928\nTuppurainen, 1989, Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients, Obstet. Gynecol., 73, 583\nMatorras, 1991, Intrapartum chemoprophylaxis of early-onset group B streptococcal disease, Eur. J. Obstet. Gynecol. Reprod. Biol., 40, 57, 10.1016\u002F0028-2243(91)90045-M\nGarland, 1991, Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis, Aust. N. Z. J. Obstet. Gynaecol., 31, 119, 10.1111\u002Fj.1479-828X.1991.tb01797.x\n2000, Hospital-based policies for prevention perinatal Group B streptococcal disease-United States, 1999, MMWR Morb. Mortal. Wkly. Rep., 49, 936\nBenitz, 1999, Antimicrobial prevention of early-onset group b streptococcal sepsis: estimates of risk reduction based on a critical literature review, Pediatrics, 103, e78, 10.1542\u002Fpeds.103.6.e78\nBloom, 1996, Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved?, Am. J. Obstet. Gynecol., 175, 974, 10.1016\u002FS0002-9378(96)80035-4\nDe Cueto, 1998, Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus, Obstet. Gynecol., 91, 112, 10.1016\u002FS0029-7844(97)00587-5\nDavis, 2001, Introduction of the new centers for disease control and prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization, Am. J. Obstet. Gynecol., 184, 603, 10.1067\u002Fmob.2001.110308\nJohnson, 2001, Optimal dosing of penicillin G in the third trimester of pregnancy for prophylaxis against group B Streptococcus, Am. J. Obstet. Gynecol., 185, 850, 10.1067\u002Fmob.2001.117353\nLin, 2000, Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998, Clin Infect Dis, 31, 76, 10.1086\u002F313936\nAndrews, 2000, Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere, Am. J. Obstet. Gynecol., 183, 859, 10.1067\u002Fmob.2000.108839\nBland, 2001, Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures, Am. J. Obstet. Gynecol., 184, 1125, 10.1067\u002Fmob.2001.115478\nFitoussi, 2001, Mechanisms of macrolide resistance in clinical group B streptococci isolated in France, Antimicrob. Agents Chemother., 45, 1889, 10.1128\u002FAAC.45.6.1889-1891.2001\nRuess, 2000, Antimicrobial susceptibility patterns of Streptococcus agalactiae in a German university hospital, Scand. J. Infect. Dis., 32, 623, 10.1080\u002F003655400459522\nMunoz, 2000, A step ahead. Infant protection through maternal immunization, Pediatr. Clin. North Am., 47, 449, 10.1016\u002FS0031-3955(05)70217-0\nKasper, 1996, Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine, J. Clin. Invest., 98, 2308, 10.1172\u002FJCI119042\nBaker, 1999, Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib, J. Infect. Dis., 179, 142, 10.1086\u002F314574\nBaker, 2000, Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women, J. Infect. Dis., 182, 1129, 10.1086\u002F315839\nVangelder, 2002, Évaluation du Strep B OIA, une méthode de détection rapide du portage de streptocoque B chez la femme enceinte, Ann. Biol. Clin. (Paris), 60, 226\nAuvray, 1999, Intérêt d'une technique rapide de dépistage vaginal du portage du streptocoque du groupe B au cours des grossesses à risque, Pathol. Biol., 47, 494\nYancey, 1992, Assessment of rapid identification tests for genital carriage of streptococci, Obstet. Gynecol., 80, 1038\nQuentin, 1993, Evaluation of a rapid latex test for direct detection of streptococcus agalactiae in various obstetrical and gynaecologic disorders, Eur. J. Clin. Microbiol. Infect. Dis., 12, 51, 10.1007\u002FBF01997059\nSchimmel, 1994, Value of rapid enzyme-linked immunoabsorbent assay for maternal vaginal group B Streptococcus colonization, J. Perinatol., 14, 198\nSimpson, 1994, Assessment of two methods for rapid intrapartum detection of vaginal group B streptococcal colonisation, J. Clin. Pathol., 47, 752, 10.1136\u002Fjcp.47.8.752\nBergeron, 2000, Rapid detection of group B streptococci in pregnant women at delivery, N. Engl. J. Med., 343, 175, 10.1056\u002FNEJM200007203430303\nKe, 2001, Molecular methods for rapid detection of group B streptococci, Expert Rev. Mol. Diagn., 1, 175, 10.1586\u002F14737159.1.2.175\nDosquet, 2003\nTurow, 2000, Group B streptococcal infection early onset disease controversies in prevention guidelines, and management strategies for the neonate, Clin Pediatr, 39, 317, 10.1177\u002F000992280003900601\nMercer, 1995, Prenatal screening for group B streptococcus. I. Impact of antepartum screening on antenatal prophylaxis and intrapartum care, Am. J. Obstet. Gynecol., 173, 837, 10.1016\u002F0002-9378(95)90351-8\nMercer, 1995, Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care, Am. J. Obstet. Gynecol., 173, 842, 10.1016\u002F0002-9378(95)90352-6\nBaker, 1999, 1997 AAP guidelines for prevention of early-onset group B streptococcal disease, Pediatrics, 103, 701, 10.1542\u002Fpeds.103.3.701\nFay, 2002, Prevention of early-onset Group B Streptococcal Disease in Neonates, N. Engl. J. Med., 347, 1798, 10.1056\u002FNEJM200211283472213\nSiegel, 1999, 1997 AAP guidelines for prevention of early-onset group B streptococcal disease, Pediatrics, 103, 197, 10.1542\u002Fpeds.103.1.197\nBeardsall, 2001, Guidelines for Group B streptococcus, Arch. Dis. Child., 84, F77, 10.1136\u002Ffn.84.1.F77b\nGotoff, 2000, Chemoprophylaxis of early-onset group B streptococcal disease in 1999, Curr. Opin. Pediatr., 12, 105, 10.1097\u002F00008480-200004000-00003\n1998, adoption of hospital policies for prevention of perinatal group b streptococcal disease-united States, 1997, MMWR Morb. Mortal. Wkly. Rep., 47, 665\nCheon-Lee, 1998, Compliance with the centers for disease control and prevention antenatal culture protocol for preventing group B streptococcal neonatal sepsis, Am. J. Obstet. Gynecol., 179, 77, 10.1016\u002FS0002-9378(98)70253-4\n2000, Hospital-based policies for prevention of perinatal group b streptococcal disease: United States, 1999, MMWR Morb. Mortal. Wkly. Rep., 49, 936\n2000, Adoption of perinatal group B streptococcal disease prevention recommendations by prenatal-care providers-Connecticut and Minnesota, 1998, JAMA, 283, 2384, 10.1001\u002Fjama.283.18.2384\n2000, Adoption of perinatal group B streptococcal disease prevention recommendations by prenatal-care providers-Connecticut and Minnesota, 1998, MMWR Morb. Mortal. Wkly. Rep., 49, 228\nDavies, 2001, McGeer AAlberta Neonatal Group B.Streptococcal network. Toronto invasive bacterial diseases network. Physicians'prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions, CMAJ, 164, 479\nConnellan, 2000, Prevention of perinatal group B streptococcal disease: screening practice in public hospitals in Victoria, Med. J. Aust., 172, 317, 10.5694\u002Fj.1326-5377.2000.tb123977.x\nFactor, 2000, Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelinesThe Active Bacterial Core Surveillance Team, Obstet. Gynecol., 95, 377, 10.1016\u002FS0029-7844(99)00549-9\nPetrova, 2002, Obstetrician preferences for prenatal strategies to reduce early-onset group B streptococcal infection in neonates: a population-based survey, Am. J. Obstet. Gynecol., 187, 709, 10.1067\u002Fmob.2002.125895\nMohle-Boetani, 1993, Comparison of prevention strategies for neonatal group B streptococcal infections: a population-based economic analysis, JAMA, 270, 1442, 10.1001\u002Fjama.1993.03510120064032\nMohle-Boetani, 1999, Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics, Pediatrics, 103, 703, 10.1542\u002Fpeds.103.4.703\nRussell, 2000, Cost consequences of elimination of the routine group B streptococcus culture at a teaching hospital, J. Matern. Fetal Med., 9, 126, 10.1002\u002F(SICI)1520-6661(200003\u002F04)9:2\u003C126::AID-MFM8>3.0.CO;2-B\nStan, 2001, Choosing a strategy to prevent neonatal early-onset group B streptococcal sepsis: economic evaluation, BJOG, 108, 840, 10.1016\u002FS0306-5456(00)00201-1\nKenyon, 2001, Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial, Lancet, 357, 989, 10.1016\u002FS0140-6736(00)04234-3\nKenyon, 2001, Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial, Lancet, 357, 979, 10.1016\u002FS0140-6736(00)04233-1\nWolf, 2000, Liberal diagnosis and treatment of intrauterine infection reduces early-onset neonatal group B streptococcal infection but not sepsis by other pathogens, Infect. Dis. Obstet. Gynecol., 8, 143, 10.1155\u002FS1064744900000181\nChen, 2001, No increase in rates of early-onset neonatal sepsis by non-group B Streptococcus or ampicillin-resistant organisms, Am. J. Obstet. Gynecol., 185, 854, 10.1067\u002Fmob.2001.117354\nKaye, 2001, Gram-negative sepsis in neonates may be rising since start of GBS prophylaxis, Clin. Infect. Dis., 32\nCordero, 1999, Bloodstream infections in a neonatal intensive-care unit: 12 years'experience with an antibiotic control program, Infect. Control Hosp. Epidemiol., 20, 242, 10.1086\u002F501619\nHervas, 2001, Increase of Enterobacter in neonatal sepsis: a twenty-two-year study, Pediatr. Infect. Dis. J., 20, 134, 10.1097\u002F00006454-200102000-00003\nShah, 1999, Increasing incidence of gram-negative rod bacteremia in a newborn intensive care unit, Pediatr. Infect. Dis. J., 18, 591, 10.1097\u002F00006454-199907000-00005\nJoseph, 1998, Neonatal early-onset Escherichia coli diseaseThe effect of intrapartum ampicillin, Arch. Pediatr. Adolesc. Med., 152, 35, 10.1001\u002Farchpedi.152.1.35\nWeisman LE, Adams KM, Lodinger BS. Is Late-Onset group B Streptococcal Disease in Infants Increasing? 2000; Pediatric Academic societies and american academy of pediatrics joint meeting, Boston, May 15 2000, Poster Session IV.\nTowers, 1998, Potential consequences of widespread antepartal use of ampicillin, Am. J. Obstet. Gynecol., 179, 879, 10.1016\u002FS0002-9378(98)70182-6\nMercer, 1999, Antibiotic use in pregnancy and drug-resistant infant sepsis, Am. J. Obstet. Gynecol., 181, 816, 10.1016\u002FS0002-9378(99)70307-8\nTowers, 2002, Antepartum use of antibiotics and early-onset neonatal sepsis: the next 4 years, Am. J. Obstet. Gynecol., 187, 495, 10.1067\u002Fmob.2002.124277\nEschenbach, 2002, Prevention of neonatal group B streptococcal infection, N. Engl. J. Med., 347, 280, 10.1056\u002FNEJMe020068\nAlkalay, 1996, Management of neonates born to mothers with group B streptoccocus colonization, J. Perinatol., 116, 470\nAujard, 1987, Traitement des infections néonatales : la place des céphalosporines, Presse Med., 16, 2176\nDe Chillaz, 1999, Antibiothérapie et infection materno-fœtale, MT Pédiatrie, 1, 55\nChavet, 2000, Les infections du nouveau-né: aspect clinique et traitement, 91\nMalik, 1999, Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit, Pediatr. Infect. Dis. J., 18, 352, 10.1097\u002F00006454-199904000-00009\nde Man, 2000, An antibiotic policy to prevent emergence of resistant bacilli, Lancet, 355, 973, 10.1016\u002FS0140-6736(00)90015-1\nLanghendries, 2000, Antibiothérapie en maternité: importance d'une utilisation rationnelle, Arch. Pediatr., 7, 292, 10.1016\u002FS0929-693X(00)80076-7\nBennet, 1986, Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens, Pediatr. Infect. Dis. J., 5, 533, 10.1097\u002F00006454-198609000-00009\nBennet, 1987, Development of the faecal anaerobic microflora after caesarean section and treatment with antibiotics in newborn infants, Infection, 15, 332, 10.1007\u002FBF01647733\nOyama, 2001, Antibiotic use during infancy promotes a shift in the T(H)1\u002FT(H)2 balance toward T(H)2-dominant immunity in mice, J. Allergy Clin. Immunol., 107, 153, 10.1067\u002Fmai.2001.111142\nSudo, 2002, An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice, Clin. Exp. Allergy, 32, 1112, 10.1046\u002Fj.1365-2222.2002.01430.x\nTowers, 1999, The capture rate of at-risk term newborns for early-onset group B streptococcal sepsis determined by a risk factor approach, Am. J. Obstet. Gynecol., 181, 1243, 10.1016\u002FS0002-9378(99)70116-X\nPetrova, 2001, Association of maternal fever during labor with neonatal and infant morbidity and mortality, Obstet. Gynecol., 98, 20, 10.1016\u002FS0029-7844(01)01361-8\nGoffinet, 1994, Déclenchement : facteurs de risque de contamination materno-fœtale à l'accouchement?, J. Gynecol. Obstet. Biol. Reprod. (Paris), 23, 444\nPylipow, 1994, Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns, Pediatrics, 93, 631, 10.1542\u002Fpeds.93.4.631\nBlond, 1992, Infection bactérienne du nouveau-né par contamination materno-fœtale : on peut se fier à l'anamnèse, J. Gynecol. Obstet. Biol. Reprod. (Paris), 21, 393\nCarbonne, 1999, Indications et modalités de déclenchement en cas de rupture prématurée des membranes. Recommandations pour la Pratique Clinique, J. Gynecol. Obstet. Biol. Reprod. (Paris), 28, 683\nMaymon, 1998, A review of randomized clinical trials of antibiotic therapy in preterm premature rupture of the membranes, Arch. Gynecol. Obstet., 261, 173, 10.1007\u002Fs004040050218\nMercer, 1997, Preterm labor and preterm premature rupture of the membranes. Diagnosis and management, Infect. Dis. Clin. North Am., 11, 177, 10.1016\u002FS0891-5520(05)70348-2\nAgence nationale d'accréditation d'évaluation en santé. Recommandations pour la pratique clinique. Diagnostic et traitement curatif de l'infection bactérienne précoce du nouveau-né. www.anaes.fr rapport 138p.\nEscobar, 2000, Neonatal sepsis workups in infants > \u002F=2000 grams at birth: a population-based study, Pediatrics, 106, 256, 10.1542\u002Fpeds.106.2.256\nLejeune, 1995, Infections néonatales précoces graves à streptocoque du groupe B. Etude multicentrique rétrospective de l'incidence et des facteurs de risque, J. Gynecol. Obstet. Biol. Reprod. (Paris), 24, 644\nTrivier, 1999, Apport des examens directs bactériologiques au diagnostic de l'infection bactérienne materno-fœtale précoce : expérience lilloise, Pathol. Biol., 47, 784\nKellogg, 1997, Frequency of low level bacteremia in infants from birth to two months of age, Pediatr. Infect. Dis. J., 16, 381, 10.1097\u002F00006454-199704000-00009\nBrown, 1995, Bacterial concentration and blood volume required for a positive blood culture, J. Perinatol., 15, 157\nSchelonka, 1996, Volume of blood required to detect common neonatal pathogens, J. Pediatr., 129, 275, 10.1016\u002FS0022-3476(96)70254-8\nWiswell, 1995, No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed?, Pediatrics, 95, 803\nKaftan, 1998, Early onset neonatal bacterial infections, Semin. Perinatol., 22, 15, 10.1016\u002FS0146-0005(98)80004-9\nSchwersenski, 1991, Lumbar puncture frequency and cerebrospinal fluid analysis in the neonate, Am. J. Dis. Child., 145, 54\nManroe, 1979, The neonatal blood count in health and disease. I. Reference values for neutrophilic cells, J. Pediatr., 95, 89, 10.1016\u002FS0022-3476(79)80096-7\nMouzinho, 1994, Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates, Pediatrics, 94, 76\nChiesa, 2003, Challenges in the esarch for the ideal laboratory aid for diagnosing neonatal infection, 349\nBenitz, 1998, Serial Serum C-Reactive Protein Levels in the Diagnosis of Neonatal Infection, Pediatrics, 102, e41, 10.1542\u002Fpeds.102.4.e41\nAutret, 1988, Comparaison des concentrations plasmatiques d'amoxicilline par voie orale et intraveineuse dans les colonisations bactériennes néonatales, Arch. Fr. Pediatr., 45, 679\nLanghendries, 2003, Antibiothérapie probabiliste dans la suspicion d'une infection néonatale précoce : tri-thérapie versus bi-thérapie, le mieux est-il l'ennemi du bien?, 403\nGouyon, 2003, Traitement des infections bactériennes materno-fœtales: voies d'administration des antibiotiques et durée du traitement, 437\nKacet, 2003, Infections materno-fœtales précoces : diagnostic et traitement. Présentation des recommandations pratiques de l'ANAES, 373\nAujard, 2003, Traitement de première intention des infections materno-fœtales. Place de la trithérapie, 421\nPhilip, 2000, Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery, Pediatrics, 106, e4, 10.1542\u002Fpeds.106.1.e4",{"ES":984},"Infección bacteriana maternofetal",{"VOID":986},"10.1016\u002Fs1283-081x(05)43395-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X05433950",[989,1004,1019,1034,1049,1064],{"id":990,"sortIndex":114,"researcher":26,"roles":991,"affiliations":992,"properties":1001},"0c04b146-7e11-40b1-8b2a-fef688ee7816",[696],[993],{"id":26,"sortIndex":36,"affiliation":994,"properties":26},{"id":995,"createTime":996,"updateTime":996,"relativeEntities":997,"slug":26,"properties":998,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"54007763-f724-48d6-8bc6-59605c4ce5d5","2024-01-05T23:33:02.151+00:00",[],{"title":999},{"VI":1000},"Service de néonatologie, Hôpital Armand Trousseau, 26, avenue du Docteur-Arnold-Netter, 75571 Paris cedex 12, France",{"title":1002},{"VI":1003},"F. Gold",{"id":1005,"sortIndex":36,"researcher":26,"roles":1006,"affiliations":1007,"properties":1016},"5ae0d1bd-0d4f-4419-a37c-0dee2ac09f8f",[696],[1008],{"id":26,"sortIndex":36,"affiliation":1009,"properties":26},{"id":1010,"createTime":1011,"updateTime":1011,"relativeEntities":1012,"slug":26,"properties":1013,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"273fdb32-7ca8-487c-af62-34c8c4d23b73","2024-01-05T23:33:02.127+00:00",[],{"title":1014},{"VI":1015},"Service de médecine néonatale, Centre de pédiatrie Gatien de Clocheville, centre hospitalier universitaire de Tours, 37044 Tours cedex 1, France",{"title":1017},{"VI":1018},"M.-H. Blond",{"id":1020,"sortIndex":111,"researcher":26,"roles":1021,"affiliations":1022,"properties":1031},"5f9d1956-eced-450b-bfe4-fb9f09e2694c",[696],[1023],{"id":26,"sortIndex":36,"affiliation":1024,"properties":26},{"id":1025,"createTime":1026,"updateTime":1026,"relativeEntities":1027,"slug":26,"properties":1028,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"105b4808-6957-48a8-91b6-d3c17cd5abb1","2024-01-05T23:33:02.176+00:00",[],{"title":1029},{"VI":1030},"Équipe immuno-pharmaco-génétique des anticorps thérapeutiques et Laboratoire d'immunologie, Hôpital Bretonneau, centre hospitalier universitaire de Tours, 37044 Tours cedex 1, France",{"title":1032},{"VI":1033},"H. Watier",{"id":1035,"sortIndex":115,"researcher":26,"roles":1036,"affiliations":1037,"properties":1046},"37fad479-cf5d-46f1-8b19-a60d56551c52",[696],[1038],{"id":26,"sortIndex":36,"affiliation":1039,"properties":26},{"id":1040,"createTime":1041,"updateTime":1041,"relativeEntities":1042,"slug":26,"properties":1043,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"cf884493-2f65-43ef-9864-e256bac9051c","2024-01-05T23:33:02.139+00:00",[],{"title":1044},{"VI":1045},"Département d'obstétrique, gynécologie et médecine de la reproduction, centre hospitalier universitaire de Rennes, 2, rue de l'Hôtel-Dieu, 35000 Rennes, France",{"title":1047},{"VI":1048},"P. Poulain",{"id":1050,"sortIndex":59,"researcher":26,"roles":1051,"affiliations":1052,"properties":1061},"52cf7942-2e93-4080-8adb-cba0fca905b8",[696],[1053],{"id":26,"sortIndex":36,"affiliation":1054,"properties":26},{"id":1055,"createTime":1056,"updateTime":1056,"relativeEntities":1057,"slug":26,"properties":1058,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c0de9e2e-90dc-4e9c-9ecf-40799c84056a","2024-01-05T23:33:02.164+00:00",[],{"title":1059},{"VI":1060},"Hôpital Robert Debré, 48, boulevard Sérurier, 75019 Paris, France",{"title":1062},{"VI":1063},"E. Bingen",{"id":1065,"sortIndex":162,"researcher":26,"roles":1066,"affiliations":1067,"properties":1076},"9553bf25-5d41-4036-8590-914141196ef8",[696],[1068],{"id":26,"sortIndex":36,"affiliation":1069,"properties":26},{"id":1070,"createTime":1071,"updateTime":1071,"relativeEntities":1072,"slug":26,"properties":1073,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1231ac4b-dda4-4939-9ad3-4e34bb8a797a","2024-01-05T23:33:02.188+00:00",[],{"title":1074},{"VI":1075},"Département de microbiologie médicale et moléculaire, EA 2639 - Unité de bactériologie - Hôpital Trousseau et Faculté de médecine - 37044 Tours cedex 1, France",{"title":1077},{"VI":1078},"R. Quentin",{"url":987,"publisher":1080,"properties":1088},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1081,"slug":662,"properties":1082,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1085,"manageAffiliations":1086,"indexDatabases":1087,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1083,"title":1084},{"VOID":665},{"EN":667},[],[],[],{"volume":1089,"pages":1091},{"VOID":1090},"41",{"VOID":1092},"1-48","2005-01-01",2005,{"id":1096,"createTime":1097,"updateTime":1098,"relativeEntities":1099,"slug":1100,"properties":1101,"entityType":688,"verifyStatus":25,"verifyTime":1108,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1109,"fullTextUrl":26,"authors":1110,"publicationType":747,"publisherRelationship":1162,"citationCount":26,"citationInfo":26,"publishDate":1174,"publishYear":869,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"65a4a892-fecd-4e7c-87d8-7bbde9bc5472","2023-12-20T23:13:46.692+00:00","2024-12-13T05:50:16.428+00:00",[],"Alumbramiento-normal-alumbramiento-dirigido-hemorragias-posparto",{"references":1102,"title":1104,"doi":1106},{"VOID":1103},"Say, 2014, Global causes of maternal death: a WHO systematic analysis, Lancet Glob Health, 2, e323, 10.1016\u002FS2214-109X(14)70227-X\nLes morts maternelles en France 2007-2009. Rapport du Comité national d’experts sur la mortalité maternelle. Inserm. http:\u002F\u002Fwww.epope-inserm.fr\u002Fwp-content\u002Fuploads\u002F2015\u002F01\u002FLes-morts-maternelles-en-France-2007-2009-Rapport-du-CNEMM.pdf.\nCollège national des gynécologues et obstétriciens français (CNGOF). Recommandations pour la pratique clinique. http:\u002F\u002Fwww.cngof.asso.fr\u002Fdata\u002FRCP\u002FCNGOF_2014_HPP.pdf.\nLansac, 1988\nWesthoff, 2013, Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage, Cochrane Database Syst Rev, CD001808\nWeeks, 2008, The retained placenta, Best Pract Res Clin Obstet Gynaecol, 22, 1103, 10.1016\u002Fj.bpobgyn.2008.07.005\nGülmezoglu, 2001, WHO multicentre randomised trial of misoprostol in the management of the third stage of labour, Lancet, 358, 689, 10.1016\u002FS0140-6736(01)05835-4\nGülmezoglu, 2007, Prostaglandins for preventing postpartum haemorrhage, Cochrane Database Syst Rev, CD000494\nWalraven, 2005, Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial, BJOG, 112, 1277, 10.1111\u002Fj.1471-0528.2005.00711.x\nDerman, 2006, Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial, Lancet, 368, 1248, 10.1016\u002FS0140-6736(06)69522-6\nLang, 2015, Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings, BMC Pregnancy Childbirth, 15, 305, 10.1186\u002Fs12884-015-0749-z\nSu, 2007, Oxytocin agonists for preventing postpartum haemorrhage, Cochrane Database Syst Rev, CD005457\nJin, 2016, Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials, J Matern Fetal Neonatal Med, 29, 400, 10.3109\u002F14767058.2014.1002394\nPizzagalli, 2015, Carbetocin versus Oxytocin during caesarean section for preventing postpartum haemorrhage, Gynecol Obstet Fertil, 43, 356, 10.1016\u002Fj.gyobfe.2015.03.004\nHofmeyr, 2015, Controlled cord traction for the third stage of labour, Cochrane Database Syst Rev, CD008020\nDupont, 2014, Prévention clinique et pharmacologique de l’hémorragie du post-partum lors de la troisième phase du travail, J Gynecol Obstet Biol Reprod, 43, 966, 10.1016\u002Fj.jgyn.2014.09.025\nCollège national des gynécologues et obstétriciens français (CNGOF). Recommandations pour la pratique clinique. Hémorragies du post-partum immédiat. 2004. http:\u002F\u002Fwww.has-sante.fr\u002Fportail\u002Fupload\u002Fdocs\u002Fapplication\u002Fpdf\u002FHPP_recos.pdf.\nCombs, 1991, Prolonged third stage of labour: morbidity and risk factors, Obstet Gynecol, 77, 863\nMagann, 2005, The length of the third stage of labor and the risk of postpartum hemorrhage, Obstet Gynecol, 105, 290, 10.1097\u002F01.AOG.0000151993.83276.70\nCarroli, 2001, Umbilical vein injection for management of retained placenta, Cochrane Database Syst Rev, CD001337\nWHO, 2006\nNardin, 2011, Umbilical vein injection for management of retained placenta, Cochrane Database Syst Rev, CD001337\nAbdel-Aleem, 2015, Nitroglycerin for management of retained placenta, Cochrane Database Syst Rev, CD007708\nDuffy, 2015, Pharmacologic intervention for retained placenta: a systematic review and meta-analysis, Obstet Gynecol, 125, 711, 10.1097\u002FAOG.0000000000000697\nDeneux-Tharaux, 2010, Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 cluster-randomised controlled trial, BJOG, 117, 1278, 10.1111\u002Fj.1471-0528.2010.02648.x\nCarroli, 2008, Epidemiology of postpartum haemorrhage: a systematic review, Best Pract Res Clin Obstet Gynaecol, 22, 999, 10.1016\u002Fj.bpobgyn.2008.08.004\nCalvert, 2012, Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and metaanalysis, PLoS One, 7, e41114, 10.1371\u002Fjournal.pone.0041114\nCortet, 2015, Severity of post-partum hemorrhage after vaginal delivery is not predictable from clinical variables available at the time post-partum hemorrhage is diagnosed, J Obstet Gynaecol Res, 41, 199, 10.1111\u002Fjog.12528\nDeneux-Tharaux, 2014, Épidémiologie de l’hémorragie du post-partum, J Gynecol Obstet Biol Reprod, 43, 936, 10.1016\u002Fj.jgyn.2014.09.023\nDahlke, 2015, Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines, Am J Obstet Gynecol, 213, 10.1016\u002Fj.ajog.2015.02.023\nSentilhes, 2016, Comparison of postpartum haemorrhage guidelines: discrepancies underline our lack of knowledge, BJOG\nDollet, 2014, Prise en charge obstétricale initiale en cas d’hémorragie du post-partum après un accouchement par voie basse, J Gynecol Obstet Biol Reprod, 43, 998, 10.1016\u002Fj.jgyn.2014.09.026\nDriessen, 2011, Postpartum hemorrhage resulting from uterine atony after vaginal delivery: factors associated with severity, Obstet Gynecol, 117, 21, 10.1097\u002FAOG.0b013e318202c845\nSchmitz, 2011, Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage, Obstet Gynecol, 118, 257, 10.1097\u002FAOG.0b013e3182255335\nGoffinet, 1995, [Practical use of sulprostone in the treatment of hemorrhages during delivery], J Gynecol Obstet Biol Reprod, 24, 209\nRamsbotham, 1855\nBakri, 2001, Tamponade-balloon for obstetrical bleeding, Int J Gynecol Obstet, 74, 139, 10.1016\u002FS0020-7292(01)00395-2\nLaas, 2012, Trends in the rate of invasive procedures after the addition of the intrauterine tamponade test to a protocol for management of severe postpartum hemorrhage, Am J Obstet Gynecol, 207, 10.1016\u002Fj.ajog.2012.08.028\nAibar, 2013, Bakri balloon for the management of postpartum hemorrhage, Acta Obstet Gynecol Scand, 92, 465, 10.1111\u002Fj.1600-0412.2012.01497.x\nGrönvall, 2013, Use of Bakri ballon tamponnade in the treatment of postpartum hemorrhage: a series of 50 cases from a tertiary teaching hospital, Acta Obstet Gynecol Scand, 92, 433, 10.1111\u002Fj.1600-0412.2012.01531.x\nOlsen, 2013, Bakri balloon effectiveness for postpartum hemorrhage: a “real world experience”, J Matern Fetal Neonatal Med, 26, 1720, 10.3109\u002F14767058.2013.796354\nVrachnis, 2013, Bakri balloon tamponade for the management of postpartum hemorrhage, Int J Gynaecol Obstet, 122, 265, 10.1016\u002Fj.ijgo.2013.03.028\nFerrazzani, 2014, Use of an intrauterine inflated catheter balloon in massive post-partum hemorrhage: a series of 52 cases, J Obstet Gynaecol Res, 40, 1603, 10.1111\u002Fjog.12404\nAlouini, 2015, Évaluation du ballon de Bakri dans les hémorragies graves du post-partum et fertilité ultérieure, J Gynecol Obstet Biol Reprod, 44, 171, 10.1016\u002Fj.jgyn.2014.05.010\nMartin, 2015, Maternal outcomes after uterine balloon tamponade for postpartum hemorrhage, Acta Obstet Gynecol Scand, 94, 399, 10.1111\u002Faogs.12591\nVintejoux, 2015, Success factors for Bakri™ balloon usage secondary to uterine atony: a retrospective, multicentre study, Aust N Z J Obstet Gynaecol, 55, 572, 10.1111\u002Fajo.12376\nRevert, 2016, Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study, BJOG\nHoward, 2015, The relationship between timing of postpartum hemorrhage interventions and adverse outcomes, Am J Obstet Gynecol, 213, 10.1016\u002Fj.ajog.2015.04.017\nAya, 2014, Prise en charge anesthésique d’une hémorragie du post-partum sévère ou résistant au traitement médical, J Gynecol Obstet Biol Reprod, 43, 1030, 10.1016\u002Fj.jgyn.2014.10.001\nPelage, 2014, Place de l’embolisation artérielle en cas d’hémorragie du post-partum, J Gynecol Obstet Biol Reprod, 43, 1063, 10.1016\u002Fj.jgyn.2014.10.002\nSentilhes L, Resch B, Gromez A. Traitements chirurgicaux et alternatives non médicales des hémorragies du post-partum. EMC (Elsevier Masson SAS, Paris), Techniques Chirurgicales Gynécologie, 41-905, 2010.\nO’Leary, 1986, Stop of hemorrhage with uterine artery ligation, Contemp Obstet Gynecol, 28, 13\nTsirulnikov, 1979, La ligature des vaisseaux utérins au cours des hémorragies obstétricales : résultats à court terme et à long terme, J Gynecol Obstet Biol Reprod, 8, 751\nBlanc, 2012, Uterine-sparing surgical management of postpartum hemorrhage: is it always effective?, Arch Gynecol Obstet, 285, 925, 10.1007\u002Fs00404-011-2083-7\nHaumonté, 2014, Prise en charge chirurgicale d’une hémorragie du post-partum, J Gynecol Obstet Biol Reprod, 43, 1083, 10.1016\u002Fj.jgyn.2014.10.003\nKayem, 2016, Invasive therapies for primary postpartum haemorrhage: a population-based study in France, BJOG, 123, 598, 10.1111\u002F1471-0528.13477\nMaraux, 2013, Hémorragie du post-partum liée à des plaies de la filière génitale : étude de 44 cas, Gynecol Obstet Fertil, 41, 692, 10.1016\u002Fj.gyobfe.2012.09.027\nFargeaudou, 2009, Severe primary postpartum hemorrhage due to genital tract laceration after operative vaginal delivery: successful treatment with transcatheter arterial embolization, Eur Radiol, 19, 2197, 10.1007\u002Fs00330-009-1413-7\nBelghiti, 2011, Oxytocin during labour and risk of severe postpartum haemorrhage: a population-based, cohort-nested case-control study, BMJ Open, 1, e000514, 10.1136\u002Fbmjopen-2011-000514\nEnquête nationale périnatale 2010. Inserm. http:\u002F\u002Fsocial-sante.gouv.fr\u002FIMG\u002Fpdf\u002FLes_naissances_en_2010_et_leur_evolution_depuis_2003.pdf.\nRicbourg, 2014, État des lieux en 2011 du respect des recommandations pour la pratique clinique du transfert maternel en cas d’hémorragie du post-partum : à propos de 84 cas, Gynecol Obstet Fertil, 42, 404, 10.1016\u002Fj.gyobfe.2012.09.006",{"ES":1105},"Alumbramiento normal, alumbramiento dirigido, hemorragias posparto",{"VOID":1107},"10.1016\u002Fs1283-081x(17)86888-0","2024-12-13T05:50:16.427+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X17868880",[1111,1126,1138],{"id":1112,"sortIndex":36,"researcher":26,"roles":1113,"affiliations":1114,"properties":1123},"e9c2bf7a-0829-4104-9a4d-09d0734c88b9",[696],[1115],{"id":26,"sortIndex":36,"affiliation":1116,"properties":26},{"id":1117,"createTime":1118,"updateTime":1118,"relativeEntities":1119,"slug":26,"properties":1120,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7c0426ca-b8c6-446f-b27c-7084d6601cea","2024-02-07T18:46:28.419+00:00",[],{"title":1121},{"VI":1122},"Service de gynécologie obstétrique, Hôpital Maison-Blanche, CHU de Reims, 45, rue Cognacq-Jay, 51092 Reims cedex, France",{"title":1124},{"VI":1125},"L. Bernaud-Bourrelier",{"id":1127,"sortIndex":115,"researcher":26,"roles":1128,"affiliations":1129,"properties":1135},"c012426d-5e70-4c46-ac5b-fe078d32c9c8",[696],[1130],{"id":26,"sortIndex":36,"affiliation":1131,"properties":26},{"id":1117,"createTime":1118,"updateTime":1118,"relativeEntities":1132,"slug":26,"properties":1133,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1134},{"VI":1122},{"title":1136},{"VI":1137},"U. Ishaque",{"id":1139,"sortIndex":114,"researcher":26,"roles":1140,"affiliations":1141,"properties":1159},"fc5ce13d-b2dc-4da2-ab13-a96c87f5b2ac",[696],[1142,1154],{"id":1143,"sortIndex":115,"affiliation":1144,"properties":1153},"715bf632-a8dc-4bd2-92d8-340e995b84a3",{"id":1145,"createTime":1146,"updateTime":1147,"relativeEntities":1148,"slug":1149,"properties":1150,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"02f20123-d5ad-488e-b38b-10fa24a3226d","2024-02-07T18:46:28.405+00:00","2025-06-11T16:19:08.782+00:00",[],"Universit%C3%A9-de-Reims-Champagne-Ardenne-9-boulevard-de-la-Paix-51100-Reims-France",{"title":1151},{"VI":1152},"Université de Reims Champagne-Ardenne, 9, boulevard de la Paix, 51100 Reims, France",{},{"id":26,"sortIndex":36,"affiliation":1155,"properties":26},{"id":1117,"createTime":1118,"updateTime":1118,"relativeEntities":1156,"slug":26,"properties":1157,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1158},{"VI":1122},{"title":1160},{"VI":1161},"R. Gabriel",{"url":1109,"publisher":1163,"properties":1171},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1164,"slug":662,"properties":1165,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1168,"manageAffiliations":1169,"indexDatabases":1170,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1166,"title":1167},{"VOID":665},{"EN":667},[],[],[],{"volume":1172,"pages":1173},{"VOID":865},{"VOID":925},"2017-12-01",{"id":1176,"createTime":1177,"updateTime":1178,"relativeEntities":1179,"slug":1180,"properties":1181,"entityType":688,"verifyStatus":25,"verifyTime":1178,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1187,"fullTextUrl":26,"authors":1188,"publicationType":747,"publisherRelationship":1206,"citationCount":26,"citationInfo":26,"publishDate":1219,"publishYear":765,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"0f587774-e313-4f47-8240-920d2465b016","2023-12-11T19:26:25.287+00:00","2024-10-09T23:45:56.374+00:00",[],"Cervicitis",{"references":1182,"title":1184,"doi":1185},{"VOID":1183},"Brunham, 1984, Mucopurulent cervicitis – The ignored counterpart in women of urethritis in men, N Engl J Med, 311, 1, 10.1056\u002FNEJM198407053110101\nMarrazzo, 2002, Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis, Obstet Gynecol, 100, 579\nManhart, 2003, Mucopurulent cervicitis and Mycoplasma genitalium, J Infect Dis, 187, 650, 10.1086\u002F367992\nTaylor, 2013, Prevalence and treatment outcome of cervicitis of unknown etiology, Sex Transm Dis, 40, 379, 10.1097\u002FOLQ.0b013e31828bfcb1\nRyan, 1998, Risk assessment, symptoms and signs as predictors of vulvovaginal and cervical infections in urban US. STD clinic: implications for use of STD algorithms, Sex Transm Infect, 74, S59\nWilmott, 1988, Mucopurulent cervicitis: a clinical entity, Genitourin Med, 64, 169\nGaydos, 2009, Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted diseases clinics, Sex Transm Dis, 36, 598, 10.1097\u002FOLQ.0b013e3181b01948\nRandjelovic, 2018, The role of polymorphonuclear leukocyte counts from urethra, cervix, and vaginal wet mount in diagnosis of nongonococcal lower genital tract infection, Infect Dis Obstet Gynecol, 2018, 8236575, 10.1155\u002F2018\u002F8236575\nMeena, 2016, Study to evaluate targeted management and syndromic management in women presenting with abnormal vaginal discharge, J Obstet Gynaecol India, 66, 534, 10.1007\u002Fs13224-016-0879-x\nWorkowski, 2018, Syphilis elimination: lessons learned again, Sex Transm Dis, 45, S80\nFarrukh, 2018, The additive value of pelvic examinations to history in predicting sexually transmitted infections for young female patients with suspected cervicitis or pelvic inflammatory disease, Ann Emerg Med, 72, 10.1016\u002Fj.annemergmed.2018.05.004\nFalk, 2010, The overall agreement of proposed definitions of mucopurulent cervicitis in women at high risk of Chlamydia infection, Acta Derm Venereol, 90, 506, 10.2340\u002F00015555-0924\nLusk, 2016, Cervicitis aetiology and case definition: a study in Australian women attending sexually transmitted infection clinics, Sex Transm Infect, 92, 175, 10.1136\u002Fsextrans-2015-052332\nWira, 2014, Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens, Am J Reprod Immunol, 72, 236, 10.1111\u002Faji.12252\nThompson, 1992, The leukocytic reaction of the human uterine cervix, Am J Reprod Immunol, 28, 85, 10.1111\u002Fj.1600-0897.1992.tb00765.x\nSuarez, 2006, Sperm transport in the female reproductive tract, Hum Reprod Update, 12, 23, 10.1093\u002Fhumupd\u002Fdmi047\nWorkowski KA, Bolan GA. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. https:\u002F\u002Fwww.cdc.gov\u002Fstd\u002Ftg2015\u002Ftg-2015-print.pdf.\nPellati, 2008, Genital tract infections infertility, Eur J Obstet Gynecol Reprod Biol, 140, 3, 10.1016\u002Fj.ejogrb.2008.03.009\nCina, 2019, Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis, Sex Transm Infect, 95, 328, 10.1136\u002Fsextrans-2018-053823\nCastle, 2001, An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV), Cancer Epidemiol Biomarkers Prev, 10, 1021\nCastle, 2004, Beyond Human Papillomavirus: the cervix, exogenous secondary factors, and the development of cervical precancer and cancer, J Low Genit Tract Dis, 8, 224, 10.1097\u002F00128360-200407000-00011\nNugent, 1992, Mucopurulent cervicitis as a predictor of chlamydial infection and adverse pregnancy outcome. the investigators of the Johns Hopkins Study of cervicitis and adverse pregnancy outcome, Sex Transm Dis, 19, 198, 10.1097\u002F00007435-199207000-00003\nAhmadi, 2018, Association of Chlamydia trachomatis infections with preterm delivery; a systematic review and meta-analysis, BMC Pregnancy Childbirth, 18, 240, 10.1186\u002Fs12884-018-1868-0\nSelhorst, 2017, Cervicovaginal inflammation facilitates acquisition of less infectious HIV variants, Clin Infect Dis, 64, 79, 10.1093\u002Fcid\u002Fciw663\nGaydos, 2006, 63\nMarrazzo, 2006, Risk factors of cervicitis among women with bacterial vaginosis, J Infect Dis, 193, 617, 10.1086\u002F500149\nRowley, 2019, Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016, Bull World Health Organ, 97, 548, 10.2471\u002FBLT.18.228486\nEstimations nationales et régionales du nombre de diagnostics d’infections à Chlamydia et à gonocoque en France en 2016. Saint-Maurice: Santé publique France; 2018. 6p. Disponible à partir de l’URL : www.santepubliquefrance.fr.\nHAS. Réévaluation de la stratégie de dépistage des infections à Chlamydia trachomatis, septembre 2018.\nPáez-Canro, 2019, Antibiotics for treating urogenital infection in men and non-pregnant women, Cochrane Database Syst Rev\nMohammadzadeh, 2019, Urogenital Chlamydia trachomatis treatment failure with azithromycin: a meta-analysis, Int J Reprod Biomed, 17, 603\nQuillin, 2018, Neisseria gonorrhoeae host adaptation and pathogenesis, Nat Rev Microbiol, 16, 226, 10.1038\u002Fnrmicro.2017.169\nCaumes, 2018, Infections sexuellement transmissibles (IST) : gonococcies, chlamydioses, syphilis, papillomavirus humains (HPV), trichomonose, N°158 UE6 ECNPilly\nWi, 2017, Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action, PLoS Med, 14, e1002344, 10.1371\u002Fjournal.pmed.1002344\nMlynarczyk-Bonikowska, 2018, Antibiotic resistance and NG-MAST sequence types of Neisseria gonorrhoeae isolates in Poland compared to the world, Postepy Dermatol Allergol, 35, 346\nTully, 1981, A newly discovered Mycoplasma in the human urogenital tract, Lancet, 1, 1288, 10.1016\u002FS0140-6736(81)92461-2\nTaylor-Robinson, 2011, Mycoplasma genitalium: from chrysalis to multicolored butterfly, Clin Microbiol Rev, 24, 498, 10.1128\u002FCMR.00006-11\nLis, 2015, Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis, Clin Infect Dis, 61, 418, 10.1093\u002Fcid\u002Fciv312\nWiesenfeld, 2017, Mycoplasma genitalium in women: current knowledge and research priorities for this recently emerged pathogen, J Infect Dis, 216, S389, 10.1093\u002Finfdis\u002Fjix198\nPereyre, 2017, Investigator group Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases, Clin Microbiol Infect, 23, 10.1016\u002Fj.cmi.2016.10.028\nSoni S, Horner P, Rayment M, Pinto-Sander N, Naous N. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018).\nDeguchi, 2016, Multidrug-resistant Mycoplasma genitalium is increasing, Clin Infect Dis, 62, 405, 10.1093\u002Fcid\u002Fciv898\nAntibiotiques de la famille des quinolones et fluoroquinolones administrés par voie systémique ou inhalée : risque d’effets indésirables invalidants, durables et potentiellement irréversibles et restrictions d’utilisation. Communiqué ANSM, avril 2019.\nJensen, 2016, 2016 European guideline on Mycoplasma genitalium infections, J Eur Acad Dermatol Venereol, 30, 1650, 10.1111\u002Fjdv.13849\nRead RH, Jensen JS, Grant ME. Efficacy of pristinamycin for treatment resistant Mycoplasma genitalium. In: Adelaide, Australia: Australasian Sexual Health Conference, 2010.\nWorkowski, 2015, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, MMWR Recomm Rep, 64, 1\nFowotade, 2013, Apparent rarity of asymptomatic herpes cervicitis in a woman with intra-uterine contraceptive device, J Public Health Afr, 4, e14, 10.4081\u002Fjphia.2013.e14\nSingh, 1999, Biological behaviour and aetiology of inflammatory cervical smears, Diagn Cytopathol, 20, 199, 10.1002\u002F(SICI)1097-0339(199904)20:4\u003C199::AID-DC3>3.0.CO;2-2\nUusküla, 2004, Atypical genital herpes: report of five cases, Scand J Infect Dis, 36, 37, 10.1080\u002F00365540310017276\nViikki, 2000, Gynaecological infections as risk determinants of subsequent cervical neoplasia, Acta Oncol, 39, 71, 10.1080\u002F028418600431003\nChauhan, 2019, Association of TLR4 and TLR9 gene polymorphisms and haplotypes with cervicitis susceptibility, PLoS One, 14, e0220330, 10.1371\u002Fjournal.pone.0220330\nProkopakis, 2002, K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix, Oncol Rep, 9, 129\nMirzaie-Kashani, 2014, Detection of human papillomavirus in chronic cervicitis, cervical adenocarcinoma, intraepithelial neoplasia and squamus cell carcinoma. Jundishapur, J Microbiol, 7, e9930\nÉvaluation de la recherche des papilloma virus humains (HPV) en dépistage primaire des lésions précancéreuses et cancéreuses du col de l’utérus et de la place du double immuno-marquage p16\u002FKi67 HAS juillet 2019. www.has-sante.fr.\nDasari, 2010, Colposcopic evaluation of cervix with persistent inflammatory Pap smear: a prospective analytical study, Cytojournal, 7, 16, 10.4103\u002F1742-6413.67112\nIshimaru, 2019, Syphilitic cervicitis with cervical cancer presenting as oropharyngeal syphilis, Intern Med, 58, 2251, 10.2169\u002Finternalmedicine.2426-18\nZhu, 2015, Cervical syphilitic lesions mimicking cervical cancer: a rare case report, Int J Infect Dis, 31, 1, 10.1016\u002Fj.ijid.2014.12.005\nMitchell, 2017, Cervical ectropion may be a cause of desquamative inflammatory vaginitis, Sex Med, 5, e212, 10.1016\u002Fj.esxm.2017.03.001\nAgah, 2019, Cryotherapy as a method for relieving symptoms of cervical ectopy: a randomized clinical trial, Oman Med J, 34, 322, 10.5001\u002Fomj.2019.63\nWorkowski, 2015, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015 [published correction appears in MMWR Recomm Rep 2015 Aug 28;64:924], MMWR Recomm Rep, 64, 1\nHamoonga, 2019, Vaginal douching in Zambia: a risk or benefit to women in the fight against cervical cancer: a retrospective cohort study, BMC Womens Health, 19, 135, 10.1186\u002Fs12905-019-0834-y\nWilkinson, 2002, Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women, Lancet Infect Dis, 2, 613, 10.1016\u002FS1473-3099(02)00396-1\nLusk, 2017, Cervicitis: a prospective observational study of empiric azithromycin treatment in women with cervicitis and non-specific cervicitis, Int J STD AIDS, 28, 120, 10.1177\u002F0956462416628319\nPaavonen, 1989, Randomized treatment of mucopurulent cervicitis with doxycycline or amoxicillin, Am J Obstet Gynecol, 161, 128, 10.1016\u002F0002-9378(89)90249-4\nSchwebke, 2002, Interrelationships of bacterial vaginosis and cervical inflammation, Sex Transm Dis, 29, 59, 10.1097\u002F00007435-200201000-00010\nDe Backer, 2006, Antibiotic susceptibility of Atopobium vaginae, BMC Infect Dis, 6, 51, 10.1186\u002F1471-2334-6-51",{"ES":1180},{"VOID":1186},"10.1016\u002Fs1283-081x(20)44040-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20440408",[1189],{"id":1190,"sortIndex":36,"researcher":26,"roles":1191,"affiliations":1192,"properties":1203},"daed47f7-376b-4e0a-bcb4-ff3740707624",[696],[1193],{"id":26,"sortIndex":36,"affiliation":1194,"properties":26},{"id":1195,"createTime":1196,"updateTime":1197,"relativeEntities":1198,"slug":1199,"properties":1200,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"06538763-c522-4171-81a3-5c78cfc57486","2024-01-10T16:43:12.676+00:00","2025-06-11T19:24:55.428+00:00",[],"Institut-Fournier-25-boulevard-Saint-Jacques-75014-Paris-France",{"title":1201},{"VI":1202},"Institut Fournier, 25, boulevard Saint-Jacques, 75014 Paris, France",{"title":1204},{"VI":1205},"J.-M. Bohbot",{"url":1187,"publisher":1207,"properties":1215},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1208,"slug":662,"properties":1209,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1212,"manageAffiliations":1213,"indexDatabases":1214,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1210,"title":1211},{"VOID":665},{"EN":667},[],[],[],{"volume":1216,"pages":1217},{"VOID":759},{"VOID":1218},"1-6","2020-08-01",{"id":1221,"createTime":1222,"updateTime":1223,"relativeEntities":1224,"slug":1225,"properties":1226,"entityType":688,"verifyStatus":25,"verifyTime":1223,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":1233,"fullTextUrl":26,"authors":1234,"publicationType":747,"publisherRelationship":1289,"citationCount":26,"citationInfo":26,"publishDate":1302,"publishYear":1303,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"4dc86ea6-10b7-4744-8244-5dd4de3b0e77","2024-02-14T14:56:39.193+00:00","2024-10-09T07:34:37.858+00:00",[],"Tratamiento-del-c%C3%A1ncer-de-endometrio",{"references":1227,"title":1229,"doi":1231},{"VOID":1228},"Scotto, 1988, Endometrial carcinoma. Clinical and pathological correlations with survival and surgical treatment, Eur. J. Gynaecol. Oncol., 9, 265\nMarziale, 1989, 426 cases of stage I endometrial carcinoma: a clinicopathological analysis, Gynecol. Oncol., 32, 278, 10.1016\u002F0090-8258(89)90624-0\nSato, 2003, Parametrial spread is a prognostic factor in endometrial carcinoma, Eur. J. Gynaecol. Oncol., 2, 241\nMorice, 2002, Quelle hystérectomie faut-il pratiquer dans les cancers de l'endomètre de stade I et II?, Bull. Cancer, 89, 157\nCreasman, 1987, Surgical pathologic spread patterns of endometrial cancer, Cancer, 60, 2035, 10.1002\u002F1097-0142(19901015)60:8+\u003C2035::AID-CNCR2820601515>3.0.CO;2-8\nMangioni, 1993, Surgical pathologic staging in apparent stage I endometrial carcinoma, Int. J. Gynecol. Cancer, 3, 373, 10.1046\u002Fj.1525-1438.1993.03060373.x\nCandiani, 1990, Evaluation of different surgical approaches in the treatment of endometrial cancer at FIGO stage I, Gynecol. Oncol., 37, 6, 10.1016\u002F0090-8258(90)90297-X\nLee, 2007, Feasibility of ovarian preservation in patients with early stage endometrial carcinoma, Gynecol. Oncol., 104, 52, 10.1016\u002Fj.ygyno.2006.07.003\nBarakat, 2006, Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study, J. Clin. Oncol., 24, 587, 10.1200\u002FJCO.2005.02.8464\nWingo, 1985, The mortality risk associated with hysterectomy, Am. J. Obstet. Gynecol., 152, 803, 10.1016\u002FS0002-9378(85)80067-3\nGemignani, 1999, Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges, Gynecol. Oncol., 73, 5, 10.1006\u002Fgyno.1998.5311\nManolitsas, 2002, Total laparoscopic hysterectomy in the management of endometrial carcinoma, J. Am. Assoc. Gynecol. Laparosc., 9, 54, 10.1016\u002FS1074-3804(05)60105-3\nHolub, 2002, Laparoscopic surgery for endometrial cancer: long-term results of a multicentric study, Eur. J. Gynaecol. Oncol., 23, 305\nEltabbakh, 2001, Laparoscopy as the primary modality for the treatment of women with endometrial cancer, Cancer, 91, 378, 10.1002\u002F1097-0142(20010115)91:2\u003C378::AID-CNCR1012>3.0.CO;2-F\nFram, 2002, Laparoscopically assisted vaginal hysterectomy vs abdominal hysterectomy in stage I endometrial cancer, Int. J. Gynecol. Cancer, 12, 57, 10.1136\u002Fijgc-00009577-200201000-00009\nTozzi, 2005, Laparoscopy vs laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study, J. Minim. Invasive Gynecol., 12, 130, 10.1016\u002Fj.jmig.2005.01.021\nWalker, 2006, Surgical staging of uterine cancer: randomized phase III trial of laparoscopy vs laparotomy - a GOG study (222), J. Clin. Oncol., 24, 18S, 10.1200\u002Fjco.2006.24.18_suppl.5010\nZullo, 2005, A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of life, Am. J. Obstet. Gynecol., 193, 1344, 10.1016\u002Fj.ajog.2005.02.131\nOccelli, 2003, Places respectives des différentes voies d'abord chirurgicales dans le traitement du cancer de l'endomètre au stade I clinique. Étude de 155 cas, Bull. Cancer, 90, 347\nEltabbakh, 2000, Hysterectomy for obese women with endometrial cancer: laparoscopy or laparotomy?, Gynecol. Oncol., 78, 329, 10.1006\u002Fgyno.2000.5914\nCaquant, 2006, La voie d'abord chirurgicale cœlio-vaginale chez les patientes obèses atteintes d'un cancer de l'endomètre, Bull. Cancer, 93, 402\nScribner, 2001, Surgical management of early-stage endometrial cancer in the elderly: is laparoscopy feasible?, Gynecol. Oncol., 83, 563, 10.1006\u002Fgyno.2001.6463\nPalomba, 2006, Visceral fat amount as predictive factor for early laparotomic conversion in obese patients with endometrial cancer, Gynecol. Oncol., 102, 128, 10.1016\u002Fj.ygyno.2006.02.002\nMarino, 1995, Staging laparotomy for endometrial carcinoma: assessment of peritoneal spread, Gynecol. Oncol., 56, 34, 10.1006\u002Fgyno.1995.1006\nRose, 1996, Endometrial carcinoma, N. Engl. J. Med., 335, 640, 10.1056\u002FNEJM199608293350907\nKadar, 1992, Positive peritoneal cytology is an adverse factor in endometrial carcinoma if there is other evidence of extrauterine disease, Gynecol. Oncol., 46, 145, 10.1016\u002F0090-8258(92)90246-F\nGrigsby, 1992, Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system, Int. J. Radiat. Oncol. Biol. Phys., 22, 905, 10.1016\u002F0360-3016(92)90786-H\nMilosevic, 1992, The clinical significance of malignant peritoneal cytology in stage I endometrial carcinoma, Int. J. Gynecol. Cancer, 2, 225, 10.1046\u002Fj.1525-1438.1992.02050225.x\nHavrilesky, 2007, The prognostic significance of positive peritoneal cytology and adnexal\u002Fserosal mestastasis in stage IIIA endometrial cancer, Gynecol. Oncol., 104, 401, 10.1016\u002Fj.ygyno.2006.08.027\nDoering, 1989, Intraoperative evaluation of depth of myometrial invasion in stage I endometrial carcinoma, Obstet. Gynecol., 74, 930\nAtad, 1994, Intraoperative frozen section examination of myometrial invasion depth in patients with endometrial carcinoma, Int. J. Gynecol. Cancer, 4, 352, 10.1046\u002Fj.1525-1438.1994.04050352.x\nShim, 1992, Accuracy of frozen-section diagnosis at surgery in clincical stage I and II endometrial carcinoma, Am. J. Obstet. Gynecol., 166, 1335, 10.1016\u002F0002-9378(92)91600-F\nSan Juan, 2006, Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen section, Int. J. Gynecol. Cancer, 16, 385, 10.1111\u002Fj.1525-1438.2006.00414.x\nBurke, 1996, Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study, Gynecol. Oncol., 62, 169, 10.1006\u002Fgyno.1996.0211\nHenriksen, 1975, The lymphatic dissemination in endometrial carcinoma: a study of 188 necropsies, Am. J. Obstet. Gynecol., 123, 570, 10.1016\u002F0002-9378(75)90877-7\nMariani, 2000, Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?, Am. J. Obstet. Gynecol., 182, 1506, 10.1067\u002Fmob.2000.107335\nMariani, 2006, Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients, Gynecol. Oncol., 101, 200, 10.1016\u002Fj.ygyno.2006.01.032\nBristow, 2003, FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival, Int. J. Gynecol. Cancer, 13, 664, 10.1136\u002Fijgc-00009577-200309000-00015\nCragun, 2005, Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer, J. Clin. Oncol., 23, 3668, 10.1200\u002FJCO.2005.04.144\nKilgore, 1995, Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling, Gynecol. Oncol., 56, 29, 10.1006\u002Fgyno.1995.1005\nChuang, 1995, Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes, Gynecol. Oncol., 58, 189, 10.1006\u002Fgyno.1995.1208\nQuerleu, 2006, Audit of preoperative and early complications of laparoscopic lymph node dissection in 1 000 gynecologic cancer patients, Am. J. Obstet. Gynecol., 195, 1287, 10.1016\u002Fj.ajog.2006.03.043\nAbu-Rustum, 2006, The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center, Gynecol. Oncol., 103, 714, 10.1016\u002Fj.ygyno.2006.03.055\nKodama, 2006, Risk factors for early and late postoperative complications of patients with endometrial cancer, Eur. J. Obstet. Gynecol. Reprod. Biol., 124, 222, 10.1016\u002Fj.ejogrb.2005.06.027\nLopez LA, Nicolau SM, Baracat FF, Goncalves WJ, Santos HV, Lopes RG, et al. Sentinel lymph node in endometrial cancer. Int J Gynecol Cancer 2007Mar26;[Epub ahead of print].\nAlektiar, 2005, Intravaginal brachytherapy alone for intermediate-risk endometrial cancer, Int. J. Radiat. Oncol. Biol. Phys., 62, 111, 10.1016\u002Fj.ijrobp.2004.09.054\nAhamad, 2005, Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size, Int. J. Radiat. Oncol. Biol. Phys., 62, 1117, 10.1016\u002Fj.ijrobp.2004.12.029\nMorrow, 1991, Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium, Gynecol. Oncol., 40, 55, 10.1016\u002F0090-8258(91)90086-K\nPoulsen, 1996, Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk cases, Int. J. Gynecol. Cancer, 6, 38, 10.1046\u002Fj.1525-1438.1996.06010038.x\nAalders, 1980, Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma, Obstet. Gynecol., 56, 419\nCreutzberg, 2000, Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial carcinoma: multicentre randomised trial, Lancet, 355, 1404, 10.1016\u002FS0140-6736(00)02139-5\nScholten, 2005, Postoperative radiotherapy for stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review, Int. J. Radiat. Oncol. Biol. Phys., 63, 834, 10.1016\u002Fj.ijrobp.2005.03.007\nKeys, 2004, A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study, Gynecol. Oncol., 92, 744, 10.1016\u002Fj.ygyno.2003.11.048\nAckerman, 1996, Endometrial carcinoma - relative effectiveness of adjuvant irradiation vs therapy reserved for relapse, Gynecol. Oncol., 60, 177, 10.1006\u002Fgyno.1996.0022\nMorgan, 1993, Isolated vaginal recurrences of endometrial carcinoma, Radiology, 189, 609, 10.1148\u002Fradiology.189.2.8210396\nCreutzberg, 2003, Survival after relapse in patients with endometrial cancer: results from a randomized trial, Gynecol. Oncol., 89, 201, 10.1016\u002FS0090-8258(03)00126-4\nRose, 1992, Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma, Int. J. Radiat. Oncol. Biol. Phys., 24, 229, 10.1016\u002F0360-3016(92)90676-9\nHamilton, 2006, The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma, Gynecol. Oncol., 103, 679, 10.1016\u002Fj.ygyno.2006.05.005\nBall, 1996, A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study, Gynecol. Oncol., 62, 278, 10.1006\u002Fgyno.1996.0227\nTrope, 1984, Treatment of recurrent endometrial adenocarcinoma with a combination of doxorubicin and cisplatin, Am. J. Obstet. Gynecol., 149, 379, 10.1016\u002F0002-9378(84)90147-9\nAapro, 2003, Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55 872) by the EORTC Gynaecological Cancer Group, Ann. Oncol., 14, 441, 10.1093\u002Fannonc\u002Fmdg112\nFleming, 2004, Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study, Ann. Oncol., 15, 1173, 10.1093\u002Fannonc\u002Fmdh316\nGaducci, 2006, Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: hormonal therapy, chemotherapy and molecularly targeted therapies, Crit. Rev. Oncol. Hematol., 58, 242, 10.1016\u002Fj.critrevonc.2005.11.002\nArimoto, 2007, Treatment with paclitaxel plus carboplatin, alone or with irradiation, of advanced or recurrent endometrial carcinoma, Gynecol. Oncol., 104, 32, 10.1016\u002Fj.ygyno.2006.07.038\nRandall, 2006, Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study, J. Clin. Oncol., 24, 36, 10.1200\u002FJCO.2004.00.7617\nSood, 2002, Concomitant cisplatin and extended field radiation therapy in patients with cervical and endometrial cancer, Int. J. Gynecol. Cancer, 12, 459, 10.1136\u002Fijgc-00009577-200209000-00009\nThigpen, 2001, Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study, J. Clin. Oncol., 19, 364, 10.1200\u002FJCO.2001.19.2.364\nJeyarajah, 1996, Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer, Gynecol. Oncol., 63, 47, 10.1006\u002Fgyno.1996.0276\nAsbury, 2002, Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study, Am. J. Clin. Oncol., 25, 557, 10.1097\u002F00000421-200212000-00004\nFiorica, 2004, Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study, Gynecol. Oncol., 92, 10, 10.1016\u002Fj.ygyno.2003.11.008\nWhitney, 2004, Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study, Gynecol. Oncol., 92, 4, 10.1016\u002Fj.ygyno.2003.09.018\nLewis, 1974, Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer, Gynecol. Oncol., 2, 368, 10.1016\u002F0090-8258(74)90028-6\nMc Donald, 1988, A randomized trial of progestagens in the primary treatment of endometrial cancer, Br. J. Obstet. Gynaecol., 95, 166\nMalkasian, 1978, Adjuvant progesterone therapy for stage I endometrial carcinoma, Int. J. Gynaecol. Obstet., 16, 48, 10.1002\u002Fj.1879-3479.1978.tb00391.x\nVergote, 1989, A randomized trial of adjuvant progestagen in early endometrial cancer, Cancer, 64, 1011, 10.1002\u002F1097-0142(19890901)64:5\u003C1011::AID-CNCR2820640507>3.0.CO;2-7\nRamirez, 2004, Hormonal therapy for the management of grade 1 endometrial carcinoma: a literature review, Gynecol. Oncol., 95, 133, 10.1016\u002Fj.ygyno.2004.06.045\nMorice, 2005, A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment, Gynecol. Oncol., 96, 245, 10.1016\u002Fj.ygyno.2004.09.034\nFung-Kee-Fung, 2006, Follow-up after primary therapy for endometrial cancer: a systematic review, Gynecol. Oncol., 101, 520, 10.1016\u002Fj.ygyno.2006.02.011\nChapman, 1996, Estrogen replacement in surgical stage I and II endometrial cancer survivors, Am. J. Obstet. Gynecol., 175, 1195, 10.1016\u002FS0002-9378(96)70027-3\nCreasman, 1986, Estrogen replacement therapy in the patient treated for endometrial cancer, Obstet. Gynecol., 67, 326\nLee, 1990, Estrogen replacement therapy following treatment for stage I endometrial carcinoma, Gynecol. Oncol., 36, 189, 10.1016\u002F0090-8258(90)90171-G\nCurran, 1988, Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system, Int. J. Radiat. Oncol. Biol. Phys., 15, 803, 10.1016\u002F0360-3016(88)90110-1\nMorris, 1996, Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration, Gynecol. Oncol., 60, 288, 10.1006\u002Fgyno.1996.0040\nAalders, 2007, Endometrial cancer – revisiting the importance of pelvic and para aortic lymph nodes, Gynecol. Oncol., 104, 222, 10.1016\u002Fj.ygyno.2006.10.013\nQuerleu, 2003, La lymphadénectomie dans les cancers de l'endomètre au stade I, Gynecol. Obstet. Fertil., 31, 1004, 10.1016\u002Fj.gyobfe.2003.06.003\nLukka, 2006, Adjuvant radiotherapy in women with stage I endometrial cancer: a systematic review, Gynecol. Oncol., 102, 361, 10.1016\u002Fj.ygyno.2006.03.008",{"ES":1230},"Tratamiento del cáncer de endometrio",{"VOID":1232},"10.1016\u002Fs1283-081x(09)70795-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X09707957",[1235,1250,1262,1274],{"id":1236,"sortIndex":114,"researcher":26,"roles":1237,"affiliations":1238,"properties":1247},"2a000bfc-bf96-4dbb-8258-1964f7012c63",[696],[1239],{"id":26,"sortIndex":36,"affiliation":1240,"properties":26},{"id":1241,"createTime":1242,"updateTime":1242,"relativeEntities":1243,"slug":26,"properties":1244,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1c2ca63b-faa4-4028-954d-98f551684a11","2024-02-14T14:56:39.360+00:00",[],{"title":1245},{"VI":1246},"Institut Claudius Regaud, 20, rue du Pont-Saint-Pierre, 31052 Toulouse cedex, France",{"title":1248},{"VI":1249},"L. Gladieff",{"id":1251,"sortIndex":59,"researcher":26,"roles":1252,"affiliations":1253,"properties":1259},"0a76fd1e-0ba0-468d-a77c-0019a45e89ae",[696],[1254],{"id":26,"sortIndex":36,"affiliation":1255,"properties":26},{"id":1241,"createTime":1242,"updateTime":1242,"relativeEntities":1256,"slug":26,"properties":1257,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1258},{"VI":1246},{"title":1260},{"VI":1261},"M. Delannes",{"id":1263,"sortIndex":36,"researcher":26,"roles":1264,"affiliations":1265,"properties":1271},"613ab062-91b4-4a5d-872f-d3dfa9b5d77d",[696],[1266],{"id":26,"sortIndex":36,"affiliation":1267,"properties":26},{"id":1241,"createTime":1242,"updateTime":1242,"relativeEntities":1268,"slug":26,"properties":1269,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1270},{"VI":1246},{"title":1272},{"VI":1273},"D. Querleu",{"id":1275,"sortIndex":115,"researcher":26,"roles":1276,"affiliations":1277,"properties":1286},"039690a6-6310-4481-bb44-d5b03fcc728c",[696],[1278],{"id":26,"sortIndex":36,"affiliation":1279,"properties":26},{"id":1280,"createTime":1281,"updateTime":1281,"relativeEntities":1282,"slug":26,"properties":1283,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"645143e2-3a4a-4f0c-98db-5cb233e6bdc7","2024-02-14T14:56:39.272+00:00",[],{"title":1284},{"VI":1285},"Centre Oscar Lambret, 2, rue Frédéric Combemale, 59000 Lille, France",{"title":1287},{"VI":1288},"F. Narducci",{"url":1233,"publisher":1290,"properties":1298},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1291,"slug":662,"properties":1292,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1295,"manageAffiliations":1296,"indexDatabases":1297,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1293,"title":1294},{"VOID":665},{"EN":667},[],[],[],{"volume":1299,"pages":1301},{"VOID":1300},"45",{"VOID":867},"2009-01-01",2009,{"id":1305,"createTime":1306,"updateTime":1307,"relativeEntities":1308,"slug":1309,"properties":1310,"entityType":688,"verifyStatus":25,"verifyTime":1307,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1317,"fullTextUrl":26,"authors":1318,"publicationType":747,"publisherRelationship":1378,"citationCount":26,"citationInfo":26,"publishDate":1391,"publishYear":1392,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e33e2165-7691-4ef0-87ff-7b731705e761","2024-01-17T20:17:37.133+00:00","2024-12-13T12:49:32.410+00:00",[],"Tratamiento-quir%C3%BArgico-de-las-lesiones-de-la-gl%C3%A1ndula-de-Bartholin-y-las-lesiones-benignas-de-la-vagina",{"references":1311,"title":1313,"doi":1315},{"VOID":1312},"Paniel BJ, Truc JB, Robichez B, Malouf A, Poitout P. Chirurgie des lésions bénignes de la vulve. EMC (Elsevier Masson SAS, Paris). Techniques chirurgicales - Urologie-Gynécologie, 41-885, 1985.\nGabriel R, Quereux C, Wahl P. Tumeurs bénignes de la vulve. EMC (Elsevier Masson SAS, Paris). Gynecologie, 510-A-10, 1995.\nKamina, 1984\nOmole, 2003, Management of Bartholin's duct cyst and gland abscess, Am Fam Physician, 68, 135\nPundir, 2008, A review of the management of diseases of the Bartholin's gland, J Obstet Gynaecol, 28, 161, 10.1080\u002F01443610801912865\nMarzano, 2004, The bartholin gland cyst: past, present, and future, J Low Genit Tract Dis, 8, 195, 10.1097\u002F00128360-200407000-00006\nAydogan Mathyk, 2018, Sexual function after Bartholin gland abscess treatment: a randomized trial of the marsupialization and excision methods, Eur J Obstet Gynecol Reprod Biol, 230, 188, 10.1016\u002Fj.ejogrb.2018.10.015\nEglin G. Marsupialisation ou ablation de la glande de Bartholin : techniques chirurgicales et indications. Extrait des mises à jour en gynécologie et obstétrique. CNGOF Tome XXXIII publié le 9.12.2009.\nCardaillac, 2019, Surgical management of Bartholin cysts and abscesses in French university hospitals, J Gynecol Obstet Hum Reprod, 48, 631, 10.1016\u002Fj.jogoh.2019.03.022\nDescamps P, Racine-Thibaud AC, Eglin G, Catala L, Lefèbvre-Lacœuille C, Sentilhes L, et al. Conduite à tenir devant une bartholinite. Extrait des mises à jour en gynécologie médicale. CNGOF Volume 2007 publié le 12.12.2007.\nCho, 1990, Window operation: an alternative treatment method for Bartholin gland cysts and abscesses, Obstet Gynecol, 76, 886, 10.1097\u002F00006250-199011000-00034\nKroese, 2017, Word catheter and marsupialisation in women with a cyst or abscess of the Bartholin gland (WoMan-trial): a randomised clinical trial, BJOG, 124, 243, 10.1111\u002F1471-0528.14281\nEglin, 2007, Comment je fais une bartholinectomie ?, Gynecol Obstet Fertil, 35, 1268, 10.1016\u002Fj.gyobfe.2007.07.038\nRock, 1997, 644\nMarkusen, 2003, Benign disorders of the vulva and vagina, 651\nCornman-Homonoff, 2018, Transarterial embolization of a Bartholin cyst before resection, J Minim Invasive Gynecol, 25, 938, 10.1016\u002Fj.jmig.2017.11.016\nHaider, 2007, The simple outpatient management of Bartholin's abscess using the Word catheter: a preliminary study, Aust N Z J Obstet Gynaecol, 47, 137, 10.1111\u002Fj.1479-828X.2007.00700.x\nWord, 1964, New instrument for office treatment of cyst and abscess of Bartholin's gland, JAMA, 190, 777, 10.1001\u002Fjama.1964.03070210083024\nGoldberg, 1970, Simplified tratment for disease of Bartholin's gland, Obstet Gynecol, 35, 109\nScott, 2003, Draining a cyst or abscess in a Bartholin's gland with a Word catheter, JAAPA, 16, 51\nOwen, 2005, Placement of a Word catheter: a resident training model, Am J Obstet Gynecol, 192, 1385, 10.1016\u002Fj.ajog.2005.02.078\nReif, 2015, Management of Bartholin's cyst and abscess using the Word catheter: implementation, recurrence rates and costs, Eur J Obstet Gynecol Reprod Biol, 190, 81, 10.1016\u002Fj.ejogrb.2015.04.008\nCobellis, 2006, Alcohol sclerotherapy: a new method for Bartholin gland cyst treatment, Minerva Ginecol, 58, 245\nKafali, 2004, Aspiration and alcohol sclerotherapy: a novel method for management of Bartholin's cyst or abscess, Eur J Obstet Gynecol Reprod Biol, 112, 98, 10.1016\u002FS0301-2115(03)00241-0\nFambrini, 2008, Carbon-dioxide laser vaporization of the Bartholin gland cyst: a retrospective analysis on 200 cases, J Minim Invasive Gynecol, 15, 327, 10.1016\u002Fj.jmig.2008.02.005\nDavis, 1985, Management of Bartholin duct cysts with the carbon dioxide laser, Obstet Gynecol, 65, 279\nBenedetti Panici, 2007, CO2 laser therapy of the Bartholin's gland cyst: surgical data and functional short- and long-term results, J Minim Invasive Gynecol, 14, 348, 10.1016\u002Fj.jmig.2006.10.015\nLashgari, 1986, Excision of Bartholin duct cysts using the CO2 laser, Obstet Gynecol, 67, 735, 10.1097\u002F00006250-198605000-00024\nMungan, 1995, Treatment of Bartholin's cyst and abscess: excision versus silver nitrate insertion, Eur J Obstet Gynecol Reprod Biol, 63, 61, 10.1016\u002F0301-2115(95)02229-Z\nErgeneli, 1999, Silver nitrate for Bartholin gland cysts, Eur J Obstet Gynecol Reprod Biol, 82, 231, 10.1016\u002FS0301-2115(98)00229-2\nYüce, 1994, Outpatient management of Bartholin gland abscesses and cysts with silver nitrate, Aust N Z J Obstet Gynaecol, 34, 93, 10.1111\u002Fj.1479-828X.1994.tb01048.x\nTuran, 1995, The treatment of Bartholin's cyst and abscess with silver nitrate, Int J Gynaecol Obstet, 48, 31, 10.1016\u002F0020-7292(94)02299-E\nOzdegirmenci, 2009, Prospective randomised study of marsupialisation versus silver nitrate application in the management of bartholin gland cysts and abscesses, J Minim Invasive Gynecol, 16, 149, 10.1016\u002Fj.jmig.2008.10.006\nWechter, 2009, Management of Bartholin duct cysts and abscesses: a systematic review, Obstet Gynecol Surv, 64, 395, 10.1097\u002FOGX.0b013e31819f9c76\nEilber, 2003, Benign cystic lesions of the vagina: a literature review, J Urol, 170, 717, 10.1097\u002F01.ju.0000062543.99821.a2\nHart, 1970, Paramesonephric mucinous cysts of the vulva, Am J Obstet Gynecol, 107, 1079, 10.1016\u002F0002-9378(70)90632-0\nKaufman, 1994\nWilkinson, 1987\nRouzier, 2005, Unusual presentation of Bartholin's gland duct cysts: anterior expansions, BJOG, 112, 1150, 10.1111\u002Fj.1471-0528.2005.00622.x\nYoussef, 1984\nCurrarino, 1982, Single vaginal ectopic ureter and Gartner's duct cyst with ipsilateral renal hypoplasia and dysplasia (or agenesis), J Urol, 128, 988, 10.1016\u002FS0022-5347(17)53311-X\nSheih, 1994, Renal hypoplasia, Gartner's duct and imperforated hemivagina: report of a case, J Formos Med Assoc, 93, 531\nDwyer, 2006, Congenital urogenital anomalies that are associated with the persistence of Gartner's duct: a review, Am J Obstet Gynecol, 195, 354, 10.1016\u002Fj.ajog.2005.10.815\nHagspiel, 1995, Giant Gartner duct cyst: magnetic resonance imaging findings, Abdom Imaging, 20, 566, 10.1007\u002FBF01256713\nFletcher, 2008, Benign masses of the female periurethral tissues and anterior vaginal wall, Curr Urol Rep, 9, 389, 10.1007\u002Fs11934-008-0067-3\nZaino RJ, Robboy SJ, Kurman RJ. Diseases of the vagina. In: Kurman R.J. Blaunstein's pathology of the female genital tract 2002; New York: Springer; 151.\nRosai, 2004, Female reproductive system: vagina\nRomanzi, 2000, Urethral diverticulum in women: diverse presentations resulting in diagnostic delay and mismanagement, J Urol, 164, 428, 10.1016\u002FS0022-5347(05)67377-6\nGanabathi, 1995, Diverticulum of the female urethra, Prog Urol, 5, 335\nHosseinzadeh, 2008, Pre- and postoperative evaluation of urethral diverticulum, AJR Am J Roentgenol, 190, 165, 10.2214\u002FAJR.07.2094",{"ES":1314},"Tratamiento quirúrgico de las lesiones de la glándula de Bartholin y las lesiones benignas de la vagina",{"VOID":1316},"10.1016\u002Fs1283-081x(22)46467-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X22464678",[1319,1334,1351,1363],{"id":1320,"sortIndex":59,"researcher":26,"roles":1321,"affiliations":1322,"properties":1331},"5c2e52d0-b2a5-42d9-8519-6f4d4ba5e407",[696],[1323],{"id":26,"sortIndex":36,"affiliation":1324,"properties":26},{"id":1325,"createTime":1326,"updateTime":1326,"relativeEntities":1327,"slug":26,"properties":1328,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1c8896d6-12bd-4872-b593-b504b2e8c36d","2024-02-12T03:26:57.966+00:00",[],{"title":1329},{"VI":1330},"Service de gynécologie obstétrique, Hôpital La-Conception, 147, boulevard Baille, 13005 Marseille, France",{"title":1332},{"VI":1333},"A. Agostini",{"id":1335,"sortIndex":36,"researcher":26,"roles":1336,"affiliations":1337,"properties":1348},"3a1277ab-adf2-4f94-86d5-9be6ddb00918",[696],[1338],{"id":26,"sortIndex":36,"affiliation":1339,"properties":26},{"id":1340,"createTime":1341,"updateTime":1342,"relativeEntities":1343,"slug":1344,"properties":1345,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"00288498-e422-4b6b-85dc-887ce2f6da9c","2023-12-12T05:27:05.124+00:00","2025-06-11T13:40:00.350+00:00",[],"Service-de-gyn%C3%A9cologie-obst%C3%A9trique-H%C3%B4pital-La-Conception-147-boulevard-Baille-13005-Marseille-France",{"title":1346},{"VI":1347},"Service de gynécologie-obstétrique, Hôpital La Conception, 147, boulevard Baille, 13005 Marseille, France",{"title":1349},{"VI":1350},"C. Tourette",{"id":1352,"sortIndex":115,"researcher":26,"roles":1353,"affiliations":1354,"properties":1360},"6292c3af-06ba-4f5d-bbd8-3f2b3dc49648",[696],[1355],{"id":26,"sortIndex":36,"affiliation":1356,"properties":26},{"id":1340,"createTime":1341,"updateTime":1342,"relativeEntities":1357,"slug":1344,"properties":1358,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1359},{"VI":1347},{"title":1361},{"VI":1362},"A. Bedel",{"id":1364,"sortIndex":114,"researcher":26,"roles":1365,"affiliations":1366,"properties":1375},"5fe6ff22-97e8-4c9a-b3bd-209a78e09edd",[696],[1367],{"id":26,"sortIndex":36,"affiliation":1368,"properties":26},{"id":1369,"createTime":1370,"updateTime":1370,"relativeEntities":1371,"slug":26,"properties":1372,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"cc568792-e93f-480e-a13c-2342d2989693","2024-01-17T20:17:37.176+00:00",[],{"title":1373},{"VI":1374},"Institut Paoli-Calmette, 232, boulevard Sainte-Marguerite, 13009 Marseille, France",{"title":1376},{"VI":1377},"M. Provansal",{"url":1317,"publisher":1379,"properties":1387},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1380,"slug":662,"properties":1381,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1384,"manageAffiliations":1385,"indexDatabases":1386,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1382,"title":1383},{"VOID":665},{"EN":667},[],[],[],{"volume":1388,"pages":1390},{"VOID":1389},"58",{"VOID":971},"2022-05-01",2022,{"id":1394,"createTime":1395,"updateTime":1396,"relativeEntities":1397,"slug":1398,"properties":1399,"entityType":688,"verifyStatus":25,"verifyTime":1396,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":1405,"fullTextUrl":26,"authors":1406,"publicationType":747,"publisherRelationship":1458,"citationCount":26,"citationInfo":26,"publishDate":1472,"publishYear":1473,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"a87a1a9c-6865-41b6-87ff-810a872d758e","2024-02-13T05:30:52.866+00:00","2024-12-13T12:49:32.514+00:00",[],"Salpingoscopia",{"references":1400,"title":1402,"doi":1403},{"VOID":1401},"Smith, 1849, New method of treating sterility by removal obstructions of the fallopian tubes, Lancet, 1, 529, 10.1016\u002FS0140-6736(02)65312-7\nMori, 1970, Tubaloscope: flexible glass fiber endoscope for intratubal observations, Endoscopy, 2, 226, 10.1055\u002Fs-0028-1098472\nCornier, 1985, Per-celioscopic ampullosalpingoscopy, J Gynecol Obstet Biol Reprod (Paris), 14, 459\nSurrey, 1999, Microendoscopy of the human fallopian tube, JAm Assoc Gynecol Laparosc, 6, 383, 10.1016\u002FS1074-3804(99)80003-6\nKerin, 1996, antegrade imaging in the management of oviductal disease, J Am Assoc Gynecol Laparosc, 3, S21, 10.1016\u002FS1074-3804(96)80203-9\nDechaud, 1998, Prospective evaluation of falloposcopy, Hum Reprod, 13, 1815, 10.1093\u002Fhumrep\u002F13.7.1815\nGordts, 2005, Transvaginal laparoscopy, Best Pract Res Clin Obstet Gynaecol, 19, 757, 10.1016\u002Fj.bpobgyn.2005.06.005\nWatrelot, 1999, Evaluation of the performance of fertiloscopy in 160 consecutive infertile patients with no obvious pathology, Hum Reprod, 14, 707, 10.1093\u002Fhumrep\u002F14.3.707\nHerrlinger, 1964, Why did vesalius not discover the fallopian tubes?, Med Hist, 8, 335, 10.1017\u002FS002572730002980X\nCorfman, 1966, An instrument for transcervical treatment of the oviducts and uterine cornua, Obstet Gynecol, 27, 880\nRouanet, 1977, An application of selective catheterization: salpingography, Preliminary note. Nouv Presse Med, 6, 2785\nCornier, 1982, Fibroscopy in gynecology: fibrohysteroscopy and fibrotuboscopy, Nouv Presse Med, 11, 2841\nPlatia, 1985, Transvaginal fluoroscopic recanalization of a proximally occluded oviduct, Fertil Steril, 44, 704, 10.1016\u002FS0015-0282(16)48992-2\nHenry-Suchet, 1985, Endoscopy of the tube (= tuboscopy): its prognostic value for tuboplasties, Acta Eur Fertil, 16, 139\nConfino, 1986, Transcervical balloon tuboplasty, Fertil Steril, 46, 963, 10.1016\u002FS0015-0282(16)49844-4\nBrosens, 1987, Salpingoscopy: a new pre-operative diagnostic tool in tubal infertility, Br J Obstet Gynaecol, 94, 768, 10.1111\u002Fj.1471-0528.1987.tb03724.x\nKerin, 1990, Falloposcopy: a microendoscopic technique for visual exploration of the human fallopian tube from the uterotubal ostium to the fimbria using a transvaginal approach, Fertil Steril, 54, 390, 10.1016\u002FS0015-0282(16)53750-9\nGordts, 1998, Transvaginal hydrolaparoscopy as an outpatient procedure for infertility investigation, Hum Reprod, 13, 99, 10.1093\u002Fhumrep\u002F13.1.99\nPuttemans, 1998, A decade of salpingoscopy, Eur J Obstet Gynecol Reprod Biol, 81, 197, 10.1016\u002FS0301-2115(98)00191-2\nMarana, 1995, Correlation between the American Fertility Society classifications of adnexal adhesions and distal tubal occlusion, salpingoscopy, and reproductive outcome in tubal surgery, Fertil Steril, 64, 924, 10.1016\u002FS0015-0282(16)57903-5\nSuzuki, 2005, Feasibility and clinical significance of endoluminal assessment by transvaginal salpingoscopy during transvaginal hydrolaparoscopy in infertile women, J Minim Invasive Gynecol, 12, 420, 10.1016\u002Fj.jmig.2005.06.014\nWatrelot, 2003, Is laparoscopy still the gold standard in infertility assessment? Acomparison of fertiloscopy versus laparoscopy in infertility. Results of an international multicentre prospective trial: the ‘FLY’ (Fertiloscopy-LaparoscopY) study, Hum Reprod, 18, 834, 10.1093\u002Fhumrep\u002Fdeg180\nDechaud, 2001, Does transvaginal hydrolaparoscopy render standard diagnostic laparoscopy obsolete for unexplained infertility investigation?, Eur J Obstet Gynecol Reprod Biol, 94, 97, 10.1016\u002FS0301-2115(00)00305-5\nWatrelot, 2002, Systematic salpingoscopy and microsalpingoscopy during fertiloscopy, J Am Assoc Gynecol Laparosc, 9, 453, 10.1016\u002FS1074-3804(05)60518-X\nWatrelot, 2003, Advances in the assessment of the uterus and fallopian tube function, Best Pract Res Clin Obstet Gynaecol, 17, 187, 10.1016\u002FS1521-6934(02)00131-1\nMarconi, 1998, Methylene blue dyeing of cellular nuclei during salpingoscopy, a new in-vivo method to evaluate vitality of tubal epithelium, Hum Reprod, 13, 3414, 10.1093\u002Fhumrep\u002F13.12.3414\nDe Bruyne, 1989, The clinical value of salpingoscopy in tubal infertility, Fertil Steril, 51, 339, 10.1016\u002FS0015-0282(16)60501-0\nMarana, 2003, Salpingoscopy, Curr Opin Obstet Gynecol, 15, 333, 10.1097\u002F01.gco.0000084245.09900.dd\nMarchino, 2001, Salpingoscopic and laparoscopic investigations in relation to fertility outcome, J AmAssoc Gynecol Laparosc, 8, 218, 10.1016\u002FS1074-3804(05)60581-6\nMarana, 1999, The prognostic role of salpingoscopy in laparoscopic tubal surgery, Hum Reprod, 14, 2991, 10.1093\u002Fhumrep\u002F14.12.2991\nDe Bruyne, 1997, The prognostic value of salpingoscopy, Hum Reprod, 12, 266, 10.1093\u002Fhumrep\u002F12.2.266\nVasquez, 1995, Prospective study of tubal mucosal lesions and fertility in hydrosalpinges, Hum Reprod, 10, 1075, 10.1093\u002Foxfordjournals.humrep.a136097\nVerhoeven, 2005, Transvaginal hydrolaparoscopy, its history and present indication, Minim Invasive Ther Allied Technol, 14, 175, 10.1080\u002F13645700510033949\nVan Tetering, 2007, Prognostic capacity of transvaginal hydrolaparoscopy to predict spontaneous pregnancy, Hum Reprod, 22, 1091, 10.1093\u002Fhumrep\u002Fdel501",{"ES":1398},{"VOID":1404},"10.1016\u002Fs1283-081x(08)70813-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X08708130",[1407,1422,1434,1446],{"id":1408,"sortIndex":115,"researcher":26,"roles":1409,"affiliations":1410,"properties":1419},"9eef688c-9e4f-478e-b81a-2a9c607ba457",[696],[1411],{"id":26,"sortIndex":36,"affiliation":1412,"properties":26},{"id":1413,"createTime":1414,"updateTime":1414,"relativeEntities":1415,"slug":26,"properties":1416,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"8918999a-8fdf-4b2d-8da1-ddf9eff2215d","2024-02-13T05:30:52.906+00:00",[],{"title":1417},{"VI":1418},"Département de médecine et biologie de la reproduction, CHU Arnaud-de-Villeneuve, Université Montpellier I, Faculté de Médecine de Montpellier, 371, avenue du doyen G.-Giraud, 34295 Montpellier cedex 5, France",{"title":1420},{"VI":1421},"C. Dechanet",{"id":1423,"sortIndex":114,"researcher":26,"roles":1424,"affiliations":1425,"properties":1431},"299bdb00-0cfd-415c-8afd-a381d8296d09",[696],[1426],{"id":26,"sortIndex":36,"affiliation":1427,"properties":26},{"id":1413,"createTime":1414,"updateTime":1414,"relativeEntities":1428,"slug":26,"properties":1429,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1430},{"VI":1418},{"title":1432},{"VI":1433},"J. Faidherbe",{"id":1435,"sortIndex":36,"researcher":26,"roles":1436,"affiliations":1437,"properties":1443},"e3dc085d-46ed-4a14-bb72-b65d1312fc39",[696],[1438],{"id":26,"sortIndex":36,"affiliation":1439,"properties":26},{"id":1413,"createTime":1414,"updateTime":1414,"relativeEntities":1440,"slug":26,"properties":1441,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1442},{"VI":1418},{"title":1444},{"VI":1445},"H. Dechaud",{"id":1447,"sortIndex":59,"researcher":26,"roles":1448,"affiliations":1449,"properties":1455},"4c9e432c-6e4f-499b-a581-2b232ef601db",[696],[1450],{"id":26,"sortIndex":36,"affiliation":1451,"properties":26},{"id":1413,"createTime":1414,"updateTime":1414,"relativeEntities":1452,"slug":26,"properties":1453,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1454},{"VI":1418},{"title":1456},{"VI":1457},"B. Hedon",{"url":1405,"publisher":1459,"properties":1467},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1460,"slug":662,"properties":1461,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1464,"manageAffiliations":1465,"indexDatabases":1466,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1462,"title":1463},{"VOID":665},{"EN":667},[],[],[],{"volume":1468,"pages":1470},{"VOID":1469},"44",{"VOID":1471},"1-5","2008-01-01",2008]